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 The interaction of GnRH with its receptor represents a crucial point for control of 
reproduction.  Additionally, the porcine GnRH receptor (GnRHR) gene is a positional 
candidate for genes influencing reproductive efficiency, residing in a similar 
chromosomal region as a QTL for ovulation rate (OR).  Gonadotropic gene expression in 
lines of swine divergent for OR may provide insight into the phenomena of increased 
litter size.  Chinese Meishan (OR=14.5), a white crossbred line selected based on an 
index of OR and embryonic survival (OR=17.8), and a Control line (OR=13.2) were 
evaluated.  Following three (Index and Control) or six (Meishan) estrous cycles, gilts 
were ovariectomized and treated with a GnRH antagonist (SB-75) or 0.9% saline at 60, 
36 and 12 hours prior to sacrifice.  Blood samples were collected prior to treatment and at 
sacrifice.  Serum LH and FSH levels were determined by RIA and RNA was extracted 
from anterior pituitary tissue.  In all lines, LH was reduced to basal levels by SB-75 
treatment; however, FSH was reduced in the Control line only.  Levels of GnRHR and 
gonadotropin subunit gene expression were measured by quantitative real-time PCR.  
Expression of the GnRHR gene prior to treatment was highest in Meishan, intermediate 
in Index and lowest in Control.  Levels of GnRHR gene expression were reduced after 
treatment in Control and Index, but not Meishan gilts.  Initial amounts of glycoprotein α-
subunit mRNA were highest in Control and Index compared to Meishan.  Further, values 
decreased following treatment in pituitaries from Control and Index lines only.  Prior to 
SB-75 treatment, FSHβ-subunit mRNA levels were higher in Control and Index 
compared to Meishan, decreasing in Control and Index, but not Meishan after treatment.  
Expression of the LHβ-subunit gene was highest in Control, intermediate in Index and 
lowest in Meishan; however amounts of mRNA decreased in Control and Index 
following treatment and remained unchanged in Meishan.  Affymetrix GeneChip® 
Porcine Genome Arrays were run on pooled RNA from each breed x treatment group in 
duplicate and gene expression analyzed.  Treatment with the GnRH antagonist, SB-75, 
decreased or increased expression of 30, 17 and 33 genes in Control, Index and Meishan 
gilts, respectively, of which 14, 7 and 11 genes were expressed at greater than 2-fold over 
gilts treated with vehicle.  Twenty-three genes were down-regulated in Control gilts and 7 
genes had increased expression levels compared to vehicle treated females.  Expression 
of 12 genes was decreased in the anterior pituitary glands of Index line gilts, whereas 
only 5 genes were up-regulated following treatment with SB-75.  Gene expression in 
ovariectomized Meishan gilts was increased in 25 and decreased in 8 genes.  Thus, gene 
expression patterns in response to treatment with a GnRH antagonist suggest differential 
mechanisms underlying gonadotrope function between lines of swine. 
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CHAPTER I 
 
INTRODUCTION 
 
Prolificacy is a fundamental measure of productivity in the swine industry.  Even 
a modest increase in litter size can have a considerable effect on the overall profitability 
of swine production.  For instance, an increase in litter size of 0.2 pigs per litter on a 
10,000 sow operation could net a producer nearly $99,000 in additional profit dependent 
on market prices (Levis, 2000).  However, average litter size in the U.S. has been nearly 
static over the past 28 years, gaining approximately 1.7 pigs per litter overall (7.17 and 
8.85 pigs per litter in 1975 and 2003, respectively) or 0.057 pigs per litter per year 
(USDA, 1976; USDA, 2004).  Thus, there is still room for improvement in litter size.      
Two primary determinants of litter size are ovulation rate and uterine capacity.  
While uterine capacity is a key component, it is not easily quantified, making selection 
for this trait difficult.  Uterine capacity aside, potential litter size is determined by 
ovulation rate.  In addition, ovulation rate can be improved in a number of ways, 
including nutritional flushing and hormonal treatment.  However, little is known about 
the mechanisms controlling increased ovulation rate.  
Ovulation rate is influenced by levels of several hormones including the 
gonadotropins, follicle stimulating hormone (FSH) and luteinizing hormone (LH).  
Gonadotropin-releasing hormone (GnRH) from the hypothalamus binds to its receptor 
(GnRHR) on gonadotrope cells of the anterior pituitary gland, stimulating the synthesis 
and secretion of both FSH and LH (Fig. 1.1).  The gonadotropins then act on the ovaries, 
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Figure 1.1.  Diagram of the Hypothalamic-Pituitary-Gonadal Axis 
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FSH stimulating follicle recruitment and LH inducing ovulation.  Steroid hormones, such 
as estrogen and progesterone, are released from the ovaries and feedback at the level of 
the hypothalamus and anterior pituitary gland to regulate subsequent GnRH and 
gonadotropin production.  Therefore, reproductive function is highly dependent on the 
interaction between GnRH and its receptor, as well as expression of the subunit genes 
encoding the gonadotropins.   
The genomic sequence for the porcine GnRHR gene was reported by Z. Jiang and 
associates (2001).  The gene for the GnRHR lies in a similar chromosomal region as a 
quantitative trait locus (QTL) for ovulation rate (Rohrer et al., 1999).  Therefore, the 
GnRHR gene represents both a physiological and positional candidate for genes 
determining ovulation rate in swine.  Further, sequence analysis reveals several 
polymorphisms within the coding sequence for the GnRHR gene between Chinese 
Meishan and white crossbred pigs, resulting in at least three amino acid substitutions.  
Meishan females produce four to five more piglets per litter than occidental white 
crossbred lines due, in part, to increased ovulation rate (White et al., 1993; Christenson et 
al., 1993).  Consistent with this model, Dr. Rodger Johnson has developed a line of pigs 
at the University of Nebraska – Lincoln (UNL) that were selected for greater than 14 
generations based on an index of ovulation rate and embryonic survival at 50 d gestation.  
This line of white crossbred pigs (Index) ovulates seven more eggs each cycle 
(Generation 10; Johnson et al., 1999) and produces 2.53 more live born piglets per litter 
than control animals (Control; Generation 19; Petry and Johnson, 2004).   
If differences in GnRHR and gonadotropin subunit gene expression between 
Meishan, Index and Control lines are determined, this could lead to a better 
 4 
understanding  of the mechanisms that determine ovulation rate.  Using these mechanistic 
differences, a DNA test could be developed to screen animals for the capacity to produce 
large litters.  Ultimately, specific genetic information from animals with an increased 
ovulation rate could be used to produce transgenic pigs.  This would allow the 
opportunity to increase ovulation rate in swine, while maintaining the beneficial traits 
characteristic of a certain breed or line.  These animals would be very valuable to pork 
production worldwide. 
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CHAPTER II 
 
Review of Literature 
 
Role of GnRH and its Receptor on Reproductive Function 
Ovulation rate may be influenced by circulating levels of FSH and LH.  The 
production of these hormones, also known as gonadotropins, is controlled by the 
reproductive axis, comprised of the hypothalamus, anterior pituitary gland and gonads 
(Fig. 1.1).  The decapeptide, gonadotropin-releasing hormone (GnRH), is released in a 
pulsatile fashion from the hypothalamus into the hypothalamo-hypophyseal portal system 
and travels to the anterior pituitary gland.   At the anterior pituitary gland, GnRH binds to 
its seven-transmembrane, G-protein-coupled receptor on the plasma membrane of 
gonadotrope cells.  Upon binding to its receptor, GnRH, through intracellular signaling 
cascades including the adenylate cyclase/cAMP and phospholipase C/inositol 
triphosphate (IP3)/diacylglycerol (DAG)/protein kinase C (PKC) pathways, stimulates the 
expression of several genes including the common α-glycoprotein subunit, FSHβ- and 
LHβ-subunits, and the GnRHR itself.  The expression of the common α-subunit, in 
combination with the specific LHβ- and FSHβ-subunit genes, is responsible for the 
synthesis of the gonadotropins within the gonadotrope cells and subsequent secretion of 
the gonadotropins into the bloodstream (Fig. 2.1).  The gonadotropins then act on the 
ovaries of the female to recruit follicles (FSH) or induce ovulation (LH).  Steroids 
produced by the ovaries, such as estradiol-17β (granulosa cells) and progesterone (luteal 
cells), provide feedback at the level of both the hypothalamus and anterior pituitary gland  
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to regulate subsequent production and release of GnRH and the gonadotropins, 
respectively. 
 
Porcine Estrous Cycle 
 The porcine estrous cycle averages 21 days, but ranges from 17 to 25 days.  The 
estrous cycle can be categorized into four periods: 1) proestrus, a time of increasing 
follicular growth and estradiol-17β production, 2) estrus, a period of sexual receptivity 
and ovulation, 3) metestrus, when formation of corpora lutea occurs and progesterone 
production begins, and 4) diestrus, a time of maximal progesterone production from fully 
functional corpora lutea.  During the estrous cycle, levels of hormones fluctuate to 
promote the selection and development of follicles to be ovulated.  Following ovulation, 
ruptured follicular tissue forms corpora lutea.  The corpora lutea produce progesterone 
which acts negatively on LH secretion by the hypothalamus and anterior pituitary.   
As the estrous cycle progresses, levels of progesterone decline (Day 12 to 14) and 
follicles begin to develop.  Around the same time, oxytocin promotes prostaglandin F2α 
production in the uterine endometrium, which is released and transported to the ovaries 
via the uterine vein and ovarian artery causing regression of the corpora lutea.  If 
fertilization of the oocytes and embryonic development occur, the presence of estradiol-
17β shunts prostaglandin F2α into the uterine lumen where it is metabolized, thus 
maintaining the corpora lutea.  In cyclic females, as the corpora lutea regress, levels of 
LH begin to rise, signaling the beginning of the follicular phase (proestrus).  Increasing 
levels of estradiol-17β, produced by the developing follicles, primes the gonadotrope 
cells and signals the preovulatory LH surge.  The preovulatory surge of LH signals the 
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ovary, and the oocytes are ovulated shortly thereafter.  A diagram of the porcine estrous 
cycle is presented in Fig. 2.2.          
 
Determination of Ovulation Rate 
Role of Gonadotropins and Their Receptors.  Sensitivity to GnRH and other 
hormones or number of GnRHRs present on the anterior pituitary gland may stimulate 
higher levels of gonadotropin production and thus increase ovulation rate.  The response 
of gonadotrope cells to GnRH to produce gonadotropins is correlated with the number of 
GnRHRs present on the cell surface (Wise et al., 1984).  There is evidence that elevated 
amounts of gonadotropins may contribute to increased ovulation rate.  A study by Knox 
et al. (2003) indicated that concentrations of both FSH and LH were elevated in lines of 
swine with increased ovulation rates (17 to 26 CL) when compared to control lines (12 to 
16 CL).  Levels of FSH could aid in determination of ovulation rate via: 1) enhanced 
recruitment of follicles during development, 2) decreased follicular atresia during the 
luteal phase, or 3) increased selection during the beginning of the follicular phase.  Van 
de Wiel et al. (1981) reported an FSH surge coinciding with the preovulatory LH surge in 
pigs, which was later substantiated (Diekman and Trout, 1984).  Immediately following 
ovulation, FSH levels rose and attained a maximum level at Day 3 after the LH surge.  
Levels of FSH then decreased until Day 7 following the LH surge and remained at an 
intermediary level for the remainder of the estrous cycle.  The FSH surge following 
ovulation has been shown to cause an increase in small follicle (<4 mm) populations in 
pigs (Guthrie et al., 1995) indicating FSH may be involved in early follicular recruitment 
at the beginning of the estrous cycle.  In contrast, higher ovulation rates may be a result  
 9 
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Figure 2.2.  Changes in reproductive hormones during the estrous cycle in the pig. 
       From Knox et al. (2003). 
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of prolonged exposure to FSH during follicular recruitment.  Exposure to increased 
concentrations of FSH during the estrous cycle may improve both the viability and 
number of recruited follicles.   
The number of follicles recruited might depend on FSH concentrations, other 
regulatory factors, or the number of FSH responsive follicles at recruitment, although it is 
not known how the latter might work (Cardenas et al., 2002).  The importance of FSH in 
follicular recruitment is indicated by FSH induced increases in ovulation rate.  
Exogenous means of increasing FSH, such as active immunization against inhibin, 
increase both FSH concentration and ovulation rate in gilts (King et al., 1993).  
Treatment with FSH on Day 15 and 16 of the estrous cycle improved ovulation rate, 
whereas no increase was observed when treatment was given after Day 16 (Hunter, 
1979).  These days of treatment correlate with follicular recruitment in the pig.  While no 
large intrinsic increase in FSH level is observed in pigs coinciding with follicular 
recruitment (Flowers et al., 1989), there is a small increase in FSH near estrus, with a 
second increase approximately 72 h later.  There is also a gradual decline in FSH from 
the time of luteolysis to estrus with a noted decline in FSH receptors (Brinkley, 1981).  
Follicle stimulating hormone appears to be important in follicular recruitment and may be 
important in later stages of development to block new recruitment after a certain 
timepoint.   
 Levels of plasma FSH during prepubertal development were higher in a line of 
gilts selected for an increased number of CL (Ford et al., 2001).  In these gilts, plasma 
FSH levels at 85 days of age correlated with subsequent ovulation rate.  In another study 
using gilts from a separate selection pool, it was suggested there was a correlation 
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between FSH at 58 and 90 days and subsequent ovulation rate, but not 124 days 
suggesting the optimal age when the correlation occurs may vary (Cassady et al., 2000).   
Ford and associates also reported that FSH concentrations of 34 day old gilts were good 
indicators of differences in FSH production between lines, with gilts selected for 
increased ovulation rate possessing a greater intrinsic capacity for FSH synthesis than 
control females.  However, by 150 days of age, FSH levels did not differ between lines, 
suggesting that negative feedback mechanisms had matured and the potential for FSH 
synthesis was no longer the limiting factor in FSH secretion (Cassady et al., 2000).  
Follicular development is dependent on the action of FSH and LH; however, the 
ability of the gonadotropins to act on follicles is dependent on expression of the 
gonadotropin receptors in ovarian tissue (Lucy et al., 2001).  Primary follicles (one layer 
of cuboidal granulosa cells) may have an initial dependence on FSH as implied by 
expression of the FSH receptor, but not LH receptor, gene in granulosa cells (Yuan et al., 
1996).  As follicles continue to develop, there is a change from FSH to LH dependence at 
the 2 to 4 mm stage (Lucy et al., 2001).  The level of LH receptor gene expression 
increases in granulosa and theca interna cells while the amount of FSH receptor mRNA 
decreases as follicular development continues (Yuan et al., 1996).  Further, FSH receptor 
mRNA is reduced in 4 mm follicles and absent in follicles greater than 4 mm.  Smaller 
follicles continue to express FSH receptor mRNA; however, larger follicles suppress FSH 
to basal levels (Lucy et al., 2001).  The loss of circulating FSH may be a mechanism to 
control the growth of new follicles whereas large antral follicles continue to grow and 
ovulate.  Levels of FSH during the preovulatory period may also play a role in the 
selection of follicles from the pool for the next period of development (Yuan et al.,  
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1996).      
 
Follicular Recruitment.  In the pig, follicular recruitment occurs between Day 
14 and 16 of the estrous cycle (Clark et al., 1982).  By Day 16, there are approximately  
40 to 60 follicles 2-6 mm in diameter between both ovaries.  Approximately 30 to 40 
percent will be selected to ovulate and the remainder will undergo atresia (Grant et al., 
1989).  Small changes in recruitment number or atretic follicles are capable of 
influencing the eventual number of ovulations.  Thus, ovulation rate is regulated within a 
relatively narrow range.  Therefore, selection and maintenance of a large follicle pool is 
critical to increased ovulation rate. 
 
GnRH Receptor and Quantitative Trait Loci for Ovulation Rate.  Several 
QTL have been suggested for ovulation rate in the pig.  A QTL is a marker at a particular 
location, or region, on a chromosome containing a gene that is associated with a 
quantitative trait that is being measured.  There is evidence for an ovulation rate QTL on 
porcine chromosome 8 (Wilkie et al., 1996; Rohrer, 1999; King et al., 2003), 9 (Cassady 
et al., 2001) and 15 (Rathje et al., 1997; Rohrer et al., 1999; Wilkie et al., 1999).  There is 
also evidence for QTL corresponding to other traits that would affect litter size including 
number of fully formed pigs on chromosome 11, number stillborn on chromosomes 5 and 
13 (Cassady et al., 2001), and uterine capacity on chromosome 8 (Rohrer et al., 1999).  
While these QTL are of interest in relation to litter size, the porcine GnRHR gene is 
located in a similar region of chromosome 8 as a QTL for ovulation rate detected in a 
Chinese Meishan-White Composite population (Rohrer, 1999).  Therefore, the GnRHR 
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gene represents a positional candidate for genes influencing ovulation rate in swine.  
Interestingly, the QTL for ovulation rate on chromosome 8 was initially identified in the 
Control and Index lines (Rathje et al., 1997), however, a study in the same lines using a 
greater number of animals failed to confirm the QTL (Cassady et al., 2001).   
The cDNA sequence for the porcine GnRHR gene has been known for some time 
(Weesner and Matteri, 1994); however, the genomic DNA sequence for the porcine 
GnRHR gene was only recently reported by Z. Jiang and co-workers (2001).  The 
identification of the genomic DNA sequence has allowed sequence analysis to be 
performed on the regulatory region (promoter) of the porcine GnRHR gene.  Several 
sequence differences have already been reported within the GnRHR gene promoter 
between Chinese Meishan and white crossbred pigs (Z. Jiang et al., 2001).  These 
differences may change how the gene is regulated and expressed.   
     
Potential Genes Affecting Ovulation Rate.  Several genes of interest in regard 
to determination of ovulation rate have been identified in sheep and comparatively 
mapped to other species.  The Fecundity Booroola (FecB) gene is a mutation at a single 
locus in the Booroola Merino breed of sheep.  The mutation is additive for ovulation rate, 
resulting in an increase of 1.65 ovulations per copy of the gene (Piper et al., 1985).  
While the number of follicles and subsequent ovulations increase in animals with this 
gene, there is a reduction in follicle size.  Follicles in FecB animals mature at a smaller 
size and are more responsive to FSH early in development.  The FecB gene has been 
mapped to ovine chromosome 6 (Montgomery et al., 1993; Montgomery et al., 1994).  
This is of interest as much of ovine chromosome 6 maps to porcine chromosome 8, on 
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which a QTL for ovulation rate has been mapped (Rohrer, 1999).  In point of fact, the 
porcine homologue of the ovine FecB gene, BMPR1B, has been mapped to the q arm of 
porcine chromosome 8 (King et al., 2003).   
The Inverdale (FecX) locus was identified in a family of Romney sheep.  The 
gene was discovered in a flock screened for increased litter size.  This gene acts in 
heterozygous carrier females to increase ovulation rate by one oocyte (Davis et al., 1991; 
Davis et al., 1995).  In contrast, homozygous females are infertile.  There is further 
evidence of multiple loci in different populations of sheep, including the Cambridge, 
Belclare and other breeds, which act in a similar manner as the FecB and FecX genes 
(Montgomery et al., 2001). 
  Prolactin may also have a role in determining ovulation rate.  Prolactin is 
involved in differentiation of mammary gland cells and signaling those cells to produce 
milk proteins.  Recently, it was discovered that the porcine prolactin receptor, found on 
chromosome 16 (Vincent et al., 1997), is polymorphic at its locus, having two possible 
alleles.  This polymorphism has become an area of interest as a possible marker for litter 
size or ovulation rate.  Based on this, van Rens et al. (2003) examined the effect this 
polymorphic site had on several traits, including ovulation rate.  This group found a 
significant effect on number of corpora lutea between the different polymorphisms, 
which equated to an increase in ovulation rate.  They noted that the polymorphism is 
within the last exon of the prolactin receptor gene.  This may cause a difference in protein 
structure, which may in turn lead to differences in receptor mediated signal transduction 
after binding of prolactin, thereby changing its action.  The increase in ovulation rate was 
attributed to an increase in the antral follicle pool, which could cause an increased 
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ovulation rate during the proceeding cycle.  While they were unable to determine whether 
the prolactin receptor was a causative gene or marker, it was indicated that it is more 
likely a candidate for ovulation rate than litter size. 
In gilts, the prolactin receptor seems to have a role in increasing ovulation rate 
with emphasis on the A allele.  In contrast, prolactin receptor knockout mice did not 
exhibit any difference in ovulation rate when compared to wild type (Grosdemouge et al., 
2003).  When these mice were superovulated, there was no effect on ovulation rate 
suggesting that prolactin had no effect on ovarian responses to gonadotropins.  Thus, it 
was determined that prolactin receptor was important for corpora lutea maintenance, but 
had no role in folliculogenesis, ovulation rate or corpora lutea formation in mice. 
One locus of the estrogen receptor gene has been associated with increased 
ovulation rate (Rothschild et al., 1996).  Using gilts of purebred Meishan and Meishan x 
Large White crossbred animals it was determined that the estrogen receptor B allele 
caused an additive effect for total number born and number born alive.  The greatest 
effect of the B allele was associated with the Meishan breed, with three pigs per litter 
over the other lines.  Meishan crossed with Large White had a first parity additive effect 
of 1.2 pigs per litter per copy of the B allele, and 0.9 pigs per litter per copy over all 
parities.  Large White (Yorkshire background) alone had a first parity additive effect of 
0.6 pigs per litter per copy of the B allele, and 0.5 pigs per litter per copy over all parities.  
Rothschild and associates also reported that the frequency of the estrogen receptor B 
allele increases as selection is focused on increasing litter size.      
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Index, Meishan and Control Lines of Swine 
Reproductive Traits.  Females of the Meishan, Index and Control lines of swine 
differ in litter size.  Traits contributing to this difference include follicular development, 
ovulation rate, embryonic survival, uterine capacity and prenatal survival throughout 
gestation (Christenson et al., 1993).  While uterine capacity is a primary determinant, it is 
not easily quantified or feasible for selection purposes.  Ovulation rate however, can be 
manipulated through nutrition or hormonal treatment. 
Meishan females produce four to five more piglets per litter than occidental white 
crossbred lines due, in part, to increased ovulation rate (White et al., 1993; Christenson et 
al., 1993).  Thus, Meishan females may harbor genetic differences and alternative 
mechanisms with the potential to enhance the reproductive performance of white 
crossbred pigs (Haley et al., 1993).  Consistent with this model, Dr. Rodger Johnson 
developed a line of pigs at the University of Nebraska – Lincoln (UNL) that were 
selected for greater than 14 generations based on an index of ovulation rate and 
embryonic survival at 50 d gestation.  This line of white crossbred pigs (Index) ovulates 
seven more eggs each cycle (Generation 10; Johnson et al., 1999) and produces 2.53 
more live born piglets per litter than control animals (Control; Generation 19; Petry and 
Johnson, 2004).  
 
Endocrine Characteristics.  One hypothesis for variances observed in ovulation 
rate is different endocrine levels throughout the estrous cycle among lines of swine.  
Another possible explanation is differences in disparity of hormone exposure, such as 
FSH, between the lines.  Concentrations of FSH, LH, estradiol-17β and progesterone did 
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not differ between Index and Control line sows during the estrous cycle (Mariscal et al., 
1998).  Similarly, peak gonadotropin concentrations and the area under the curve for FSH 
and LH did not differ between Large White and Meishan sows prior to the LH surge 
(Hunter et al., 1996).  In contrast, Knox et al. (2003) reported FSH and LH levels were 
increased during the ovulatory phase in the Index line.  Also, FSH was elevated during 
the luteal phase and was associated with an increased ovulation rate in Index compared to  
Control line gilts.   
 When recently ovariectomized gilts were challenged with estradiol-17β, response 
of LH secretion was greater in a hybrid white line of pigs compared to Meishan (Tilton et 
al., 1994).  Levels of LH were higher in Meishan gilts compared to white line pigs prior 
to ovariectomy.  Mean plasma LH was comparable between the lines up to 60 h after 
treatment with estradiol-17β, but were again greater in Meishan gilts after 60 h.  Levels 
of FSH were higher prior to and following estradiol-17β treatment in Meishan gilts but 
followed a similar pattern of secretion to that of the hybrid white line.  Gilts from the 
previous estradiol-17β study were subjected to an intramuscular bolus injection of GnRH 
approximately 14 days following ovariectomy.  Plasma levels of LH were greater in the 
hybrid white line compared to Meishan gilts.  Levels of FSH were higher in the hybrid 
white line prior to, and following GnRH administration, with the pattern of secretion 
differing following GnRH challenge.  When treated with porcine follicular fluid devoid 
of steroid hormones, FSH levels declined 35 and 20% in hybrid white line and Meishan 
gilts, respectively, with no effect on LH levels (Tilton et al., 1994).    Levels of inhibin 
were significantly higher during the preovulatory period in Meishan gilts but were not 
accompanied by a reduction in FSH levels (Hasagawa et al., 1988).  Hunter and others 
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(1996) reported that inhibin was increased before and after the LH surge in Meishan 
compared to Large White females, and was directly correlated to ovulation rate.  These 
data suggest that Meishan females may be less sensitive to inhibitory feedback by the 
ovary and differential regulation of gonadotropin secretion may be an important 
contributor to the higher prolificacy observed in Meishan females. 
Following GnRH challenge, Meishan sows had a smaller LH surge and lower 
plasma LH levels than Large White contemporaries (Wise et al., 2001) which is in 
agreement with previous studies in gilts by Tilton and associates (1994).  Following 
ovariectomy, LH levels increased more rapidly and peaked at a higher level in Large 
White than Meishan sows.  When the ovariectomized sows were treated with SB-75, 
Meishan sows exhibited a more swift recovery of LH levels than their Large White 
contemporaries.  A long decline in FSH levels was observed in Meishan sows following 
SB-75 treatment whereas little change was seen in Large White females, suggesting a 
slower clearance rate of FSH in Meishan sows. 
  
Follicular dynamics.  Follicular comparisons were made between Meishan and 
Large White hybrid gilts following their fifth estrous cycle.  Biggs et al. (1993) reported 
that Meishan gilts had smaller follicles that contained less follicular fluid, but had similar 
amounts of DNA in the granulosa cell layer and a higher concentration of estradiol-17β 
within the follicle compared to Large White hybrids.  The higher concentration of 
estradiol-17β indicates that the Meishan follicles were more advanced in development 
than their time-wise contemporary follicles in the Large White hybrids.  This difference 
may be explained by the amount of aromatase activity in granulosa cells, which is greater 
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in Meishan gilts (Hunter et al., 1993), as the capacity would exist for more androgens to 
be converted into estrogens.  The increased concentration of estradiol-17β within the 
follicle may provide a more optimal environment for oocyte maturation. 
Disparity among the developing follicles can also impact ovulation rate.  This is 
evident when a comparison is made between Chinese Meishan and Large White females.  
Meishan sows have a greater ovulation rate than their Large White contemporaries (27.7 
compared to 17.6 corpora lutea; Miller et al, 1998).  Meishan females also have a greater 
number of follicles that are 2 mm or larger on Day 16 of the estrous cycle than Large 
White females.  However, in Large White sows the number of follicles decreases 
between Day 16 and 19, whereas the number of follicles remains unchanged in Meishan 
sows (Miller et al., 1998).   
The same is true for animals of the UNL Index line (Yen et al., 2005).  Gilts of 
the Index and Control lines begin the follicular phase of the estrous cycle with 
recruitment of a similar number of follicles ≥ 2 mm.  During progression of the follicular 
phase, gilts of the Index line are able to maintain a larger selection pool containing more 
estrogen-active follicles than Controls (Yen et al., 2005).  It is also possible that follicles 
ovulated in Index females are smaller than those of Control females (Kelly et al., 1988).     
 
Oocyte Development.  Pope et al. (1990) postulated that less advanced oocytes 
became less advanced embryos and succumbed to early mortality.  Pope and associates 
also noted that in Large White gilts, 70% of oocytes were ovulated in a short amount of 
time, while the remaining 30% were ovulated over a more prolonged period of time, with 
oocytes ovulated first becoming more developed and viable.   Upon comparison of 
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follicles in Meishan and Large White hybrid gilts within 8 h of ovulation, it was found 
that oocytes of Meishan gilts were at more advanced stages (Hunter et al., 1993).  Thus, 
increased litter size in the Meishan breed may be attributed to more mature oocytes being 
ovulated, fertilized and yielding more advanced embryos, increasing the odds of survival.  
Overall, Meishan females appear to have a shorter luteal and longer follicular phase than 
White crossbreds (Hunter et al., 1996).  This may cause recruitment to occur over a 
longer period of time allowing a larger number of oocytes to undergo final maturation 
and ovulation. 
 
GnRH and GnRH Receptor 
Structure.  Binding of the decapeptide, GnRH (pGlu-His-Trp-Ser-Tyr-Gly-Leu-
Arg-Pro-Gly-NH2), to its cognate receptor on the plasma membrane of gonadotropes 
within the anterior pituitary gland is a fundamental regulator of reproductive function.  
Released in a pulsatile manner from the hypothalamus, GnRH binding to its receptor 
stimulates release of the gonadotropins, FSH and LH.  Each pulse of GnRH stimulates a 
complimentary LH pulse, but FSH pulses are less distinctive (Millar et al., 2004).  
Gonadotropin-releasing hormone receptors have an amino terminus, followed by seven 
transmembrane α-helix domains connected by three extracellular domains and three 
intracellular loops, typical of G-protein-coupled receptors (GPCRs; Fig. 2.3).  
Conservation of the 10 amino acids and amino and carboxyl termini among GnRH 
species indicates the importance of these features in binding.  However, variability in 
position 8 of functional GnRH analogues suggests that most residues are acceptable for 
this position.  Nevertheless, for high-affinity binding to take place at the mammalian  
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Figure 2.3.  Structural representation of the human GnRHR.  Adapted from Neill (2002).  
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GnRHR, arginine must be in position 8 (Sealfon et al., 1997).  Thus, it appears that 
selectivity of different GnRHRs is dependent on the amino acid residue that occupies 
position 8 in GnRH ligands. 
 
 Internalization and Recycling.  Following synthesis, GPCRs are packaged in the 
Golgi apparatus and transported to the cell membrane.  Once at the membrane, GPCRs 
may undergo endocytosis into endosomes whether an agonist is present or not, however 
agonist induced endocytosis is much more rapid (Koenig and Edwardson, 1997).  Once 
within the endosome, GPCRs can either be recycled back to the membrane or targeted to 
lysosomes for degradation (Fig 2.4).  It appears that this determination is made in the 
early endosome, with the default pathway being recycling (Koeing and Edwardson, 
1997).  Dissociation of the ligand from receptor is accomplished by increasing acidity 
within the endosome.  Thus, receptors on the membrane are derived from both de novo 
synthesis and recycling of internalized receptors (Koeing and Edwardson, 1994). 
 
Role of C-terminal Tail.  G-protein-coupled receptor activation involves 
phosphorylation of the receptor and is typically followed by internalization and 
desensitization.  However, loss of the receptor due to internalization does not appear to be 
required for the gonadotrope to become desensitized to GnRH or an antagonist (Gorospe 
and Conn, 1987). Phosphorylation by agonist binding is usually more rapid (McArdle et 
al., 2002).  G-protein-coupled receptors are internalized by endocytosis via clatherin-
coated vesicles whose formation is controlled by a dynamin collar that pinches off the 
vesicle from the membrane following ligand binding (Schmid, 1998).  Once receptors  
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Figure 2.4.  Diagram of receptor cycling.  Once internalized, the ligand dissociates from  
         the receptor, which is either recycled or targeted to lysosomes for        
         degradation.  Adapted from Koenig and Edwardson (1997). 
 
 
ligand 
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have been internalized they are either recycled to the cell membrane, or marked for 
degradation by lysosomes.  Unique to the mammalian GnRHR is the absence of a 
carboxy-terminal tail normally present in all G-protein-coupled receptors, including 
GnRH Type II receptors (GnRH II-R) and non-mammalian GnRHR.  Stimulation of G-
protein-coupled receptors causes phosphorylation of intracellular amino acids, some of 
which are situated within the C-terminal tail.  The lack of a C-terminal tail in the 
mammalian GnRHR may explain its inability for rapid desensitization, as key 
phosphorylation sites may be absent (Heding et al., 1998). 
Several studies have demonstrated the importance of the cytoplasmic C-terminal 
tail in internalization and desensitization.  By attaching the C-terminal tail of rat 
thyrotropin-releasing hormone receptor to the rat GnRHR, Heding and associates (1998) 
demonstrated an increase in internalization rate and desensitization of the mutant GnRHR 
compared to wild type rat GnRHR.  Adding the C-terminal tail of the catfish GnRHR to 
the rat GnRHR caused agonist-induced phosphorylation and rapid desensitization 
(Willars et al., 1998).  β-arrestin is important in desensitization, internalization and down-
regulation of the receptor (McArdle et al., 2002).  Phosphorylation of amino acids in the 
C-terminal tail appears to be important to facilitate β-arrestin binding.  It would appear 
that the absence of the C-terminal tail in GnRHR causes their resistance to desensitization 
(Davidson et al., 1994).  Dynamin has been implicated in fission of clatherin-coated 
vesicles prior to internalization (Takei et al., 1995).  To explore the dynamin dependence 
of GnRHR internalization, Heding et al. (2000) co-transfected COS cells with GnRHR 
and a GTPase-deficient mutant of dynamin.  In this study, the mutant dynamin inhibited 
internalization of GnRHR more in catfish GnRHR than rat.  Thus, based on the previous 
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data, it would appear that the C-terminus is important not only in β-arrestin translocation, 
but may also target the receptor for dynamin-dependent internalization (Miller and 
Lefkowitz, 2001). 
 
Processing.  Once internalized the GnRH ligand and GnRHR are processed 
separately (Cornea et al., 1999).  To demonstrate this, GH3 cells were transfected with 
GnRHR and treated with a GnRH antagonist.  Internal cell concentration of the GnRH 
agonist increased for 2 h, whereas the concentration of GnRHR peaked 80 minutes 
following activation.  Cornea and associates (1999) also noticed that there were still free 
GnRHR on the cell membrane even after the agonist had been internalized.  It was 
suggested that following internalization GnRH is freed from GnRHRs and receptors can 
be transported back to the cell membrane.    
 In addition, estradiol has a role in priming GnRHR numbers on the membrane of 
gonadotrope cells.  Treatment of ovine pituitary cells with estradiol caused an increase in 
the number of GnRHRs on the cell membrane by approximately 100%, but rate of 
internalization was not changed (Hashizume et al., 2001).  It does not appear that the 
percentage of GnRHRs that are internalized depends on the number of GnRHR within the 
membrane, or that a decrease in receptor internalization is the cause of enhanced pituitary 
sensitivity to GnRH by estradiol.            
 
Levels of GnRH Receptor in Gonadotropes 
Determination of the number of GnRHR present on the plasma membrane of 
gonadotrope cells within the anterior pituitary gland is a dynamic process and depends on 
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the physiological state of the individual.  In the rat anterior pituitary gland, there were 
alterations in the number of GnRHRs, but not affinity, during cyclicity, lactation and 
aging (Marian et al., 1981).  The absence of a change in binding affinity, but fluctuation 
in numbers of GnRHR, during the estrous cycle has also been observed in mice (Naik et 
al., 1984) and hamsters (Adams et al., 1981).  Marian and associates (1981) also reported 
that the number of GnRHR among age groups was highest in weanling pups, although 
they had low levels of gonadotropin secretion.  Levels of GnRHR in pregnant beef 
heifers were approximately 74% the level of those of estrus, whereas anestrous heifers 
had the lowest number of GnRHR at a level that was 45% that of concentrations detected 
during estrus (Schoenemann et al., 1985).    
During the rat estrous cycle, GnRHR levels were lowest in the late afternoon and 
evening of estrus through metestrus.  The numbers of GnRHR doubled by the evening of 
diestrus, remained elevated through the afternoon of proestrus, and declined coinciding 
with the preovulatory LH surge (Clayton et al., 1980).  Funabashi and associates (1994) 
also reported that the number of GnRHRs increased during diestrus (Day 3) and remained 
elevated through the afternoon of proestrus (Day 4) of the rat estrous cycle.  The amount 
of GnRHRs was greatest immediately prior to the preovulatory LH surge in the ewe 
(Crowder and Nett, 1984) and hamster (Adams et al., 1981), with levels declining 
following the LH surge.  In beef heifers, pituitary GnRHR concentrations were highest at 
estrus, declined by Day 7, then returned to estrus levels by Day 14 (Schoenemann et al., 
1985).  In contrast, Nett and associates (1987) reported that levels of GnRHR in beef 
heifers did not change on Day 6 through 18 following estrus.  There was a significant 
decrease in receptor numbers from Day 19 through 21 which may be attributed to down- 
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regulation of receptors by increased GnRH pulse frequency.     
The physiological changes observed in the number of GnRHRs in the anterior 
pituitary gland may be due to an increase in mRNA levels as changes in levels of GnRHR 
mRNA preceded changes in protein levels (Kakar et al., 1994).  In rats, levels of GnRHR 
mRNA were highest on the afternoon of proestrus and coincided with a time when 
numbers of GnRHRs are high and GnRH sensitivity is greatest (Bauer-Dantoin et al., 
1993).  In contrast, treatment with an antagonist of GnRH had no effect on GnRHR 
mRNA levels during the luteal period.  The highest levels of GnRHR mRNA were 
observed one day prior to estrus in the ewe.  Levels of GnRHR mRNA declined 60 and 
80% during the LH surge and 24 h following estrus, respectively, which closely 
resembled reported levels of GnRHR (Padmanabhan et al., 1995).  There was a 40% 
reduction in GnRHR mRNA levels in female rats 36 h following ovariectomy (Yasin et 
al., 1995).  By 48 h, however, GnRHR mRNA levels had returned to pre-ovariectomy 
levels, and continued to increase through Day 7.            
In mice, ovariectomy decreased the binding of GnRH in the anterior pituitary 
gland (Naik et al., 1985).  A decrease in GnRHR was initially detected 12 h following 
ovariectomy (Naik et al., 1984).  The decline was followed by a brief increase in GnRHR 
numbers at 24 h, then a progressive decline through Day 7 post ovariectomy.  Long term 
ovariectomy resulted in a 60% decrease in binding capacity (number of receptors 
available for binding) compared to intact controls at 2 weeks and was sustained through 2 
months.  Likewise, rats immunized against GnRH had significantly reduced levels of 
GnRHR (Popkin and Fraser, 1985).  However, pituitary GnRHR levels were not 
completely abolished by long-term immunization to GnRH, indicating an independent  
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basal level of GnRHR regulation exists.          
 The suppression of GnRH during lactation due to the suckling response causes a 
reduction in the amount of GnRHRs available.  Levels of GnRHR mRNA in rats were 
reduced during lactation compared to animals that were ovariectomized (Funabashi et al., 
1994).  Similarly, compared to cycling female mice, the GnRHR concentration in the  
anterior pituitary glands of lactating females was reduced by 40% (Naik et al., 1984). 
 
GnRH II and GnRH II Receptor 
Structure.  In addition to well-characterized, mammalian GnRH, a second form, 
Type II GnRH, was isolated in the chicken (Miyamoto et al., 1984).  Type II GnRH 
(GnRH II; pGlu-His-Trp-Ser-His-Gly-Trp-Tyr-Pro-Gly-NH2) is highly conserved among 
species, and differs from Type I GnRH (GnRH) at positions 5, 7 and 8 (Wang et al., 
2004).  The reason for such a high level of conservation is not known, as GnRH II is 
identical in all species in which it has been discovered (White et al., 1998).  The Type II 
GnRH receptor (GnRH II-R) has been found in the catfish (Tensen at al., 1997), bullfrog 
(L. Wang et al., 2001), primates (Lescheid et al., 1997; Millar et al., 2001) and marmoset 
(Terasawa, 2003; Temple et al., 2003).   The high level of conservation may be the result 
of the ability of GnRH II to bind multiple receptors and differing structural requirements 
for those receptors (Millar, 2003).  It may also allow GnRH II to serve alternative 
functions at different locations in the body (White et al., 1998).  In addition to primates, 
the GnRH II-R has been identified in the pig (Neill et al., 2004) which is 91% 
homologous to GnRH II-R in the monkey.  Interestingly, an alternatively spliced 5-
transmembrane GnRH II-R has been discovered in pigs as well (Neill et al., 2004).  This 
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receptor is missing the first two transmembrane domains so that the extracellular N-
terminal end is linked directly to transmembrane domain 3.  Similar to the GnRHR, the 
GnRH II-R signals via the Gq pathway (Tensen et al., 1997).  Structurally, GnRH II-R 
possesses a C-terminal tail that the GnRHR is lacking (Millar, 2003).  The C-terminal tail 
has been implicated in the rapid desensitization of the GnRH II-R.  For example, when 
treated with GnRH II the monkey GnRH II-R underwent desensitization whereas the 
human GnRHR did not when treated with the GnRH agonist, triptorelin (Neill, 2002).   
 
GnRH II Receptor Gene.  The GnRH II-R gene has been identified in several 
other species, however a functional, full-length mRNA has not been found.  In sheep, the 
GnRH II-R gene is located in a similar position in relation to other genes as the human.  
The gene consists of three exons and two introns, but contains a premature stop codon in 
exon 1, preventing functional GnRH II-Rs from being synthesized (Gault et al., 2004).  
The human GnRH II-R gene contains two flaws that prevent it from being properly 
translated (Neill et al., 2004).  The first is a shift that eliminates a transcription start site 
near the N-terminus.  The second flaw is a single base substitution that changes the Arg 
at position 179 to a premature stop codon that would terminate translation in exon 2 
(Morgan et al., 2003).  Likewise, in cattle and chimpanzees there is a shift in sequence 
resulting in a premature stop codon (Morgan et al., 2003).   In each case, the potential for 
a full length protein is present; however the sequence shift would have to be overcome. 
 
Distribution.  A small amount of GnRH II has been found in the hypothalamus 
with proximity to the hypothalamo-hypophyseal portal system in primates, but in greatly 
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reduced amounts compared to GnRH (Lescheid et al., 1997).  However, most 
gonadotropes in the anterior pituitary of the marmoset express both GnRHR and GnRH 
II-R (Millar et al., 2001).  Distribution of GnRH II receptor in the midbrain as well as 
other extra-hypothalamic regions of the brain may be indicative of a neurotransmitter 
involved in sex behavior (Terasawa, 2003).  Sexual receptivity increased in energy 
restricted female musk shrews within minutes of treatment with GnRH II versus 
untreated controls, potentially through actions at the GnRH II-R (Temple et al., 2003).   
 
Receptor Affinity.  There is little chance that GnRH has an effect at the GnRH 
II-R, especially since GnRH was 400 times less active (Neill et al., 2004) and had 1/421 
the potency (Neill, 2002) as GnRH II at the GnRH II-R.  The difference in affinity for 
each of the ligands at their respective receptors may be due to their amino acid content.  
The Trp and Tyr at positions 7 and 8, respectively, may be responsible for affinity of 
GnRH II to its receptor (Maiti et al., 2003).  Modified GnRH containing the two residues 
were able to interact with monkey GnRH II-R in a similar fashion as native GnRH II.  
Also, similar to GnRH, substitution of a small D-amino acid, such as D-Ala in position 6 
caused an increase in affinity of GnRH II for its receptor (Maiti et al., 2003).  
Gonadotropin-releasing hormone II receptors have a high affinity for GnRH II and 
promote higher stimulation of inositol phosphate production following binding GnRH II-
R than GnRH (Millar et al., 2001).  It is also interesting to note that some GnRH 
antagonists act as agonists at GnRH II-R, potentially due to conformational changes 
following the ligand binding the receptor activating alternative signaling cascades. 
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Function.  The function of GnRH II and its receptor are not well known, but 
several hypotheses exist.  One thought is that GnRH II may play a role in the control of 
the gonadotropins, specifically with preferential stimulation of FSH secretion (Yu et al., 
1997).  Evidence for this is found in the chicken (Millar et al., 1986) and male sheep 
(Millar et al., 2001).  However, in male rhesus monkey pituitary cell cultures, GnRH II 
stimulated LH and FSH release over basal levels, but was less effective than GnRH.  
Okada and associates (2003) also found that the potent GnRH antagonist, antide, blocked 
GnRH II stimulated secretion of LH and FSH.  A similar level of gonadotropin release, as 
well as blockade of stimulated gonadotropin secretion by antide, was also seen in female 
monkeys (Densmore and Urbanski, 2003).  It was also noted that GnRH II did not 
enhance gonadotropin secretion when added to cultures concurrently treated with GnRH, 
implying that GnRH II does not act on GnRHR (Okada et al., 2003).   
When treated with GnRH II or an agonist of GnRH II, mRNA levels for both 
GnRHR and GnRH II were down-regulated in human granulosa-luteal cells (Kang et al., 
2001).  In contrast, treatment with FSH and hCG yielded dose-dependent increases in 
GnRH II mRNA levels, but decreased GnRH I mRNA levels.  Kang and associates 
(2001) also reported that GnRH II caused a decrease in FSH and LH receptor mRNA 
levels.  It appears that GnRH and GnRH II are differentially regulated by their response 
to levels of homologous ligand (biphasic reaction of GnRH and down-regulation of 
GnRH II). 
 
SB-75 (Cetrorelix) 
Also known as Cetrorelix, the specific GnRH antagonist, SB-75, ([Ac-D- 
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Nal(2)1,D-Phe(4Cl)2,D-Pal(3)3,D-Cit6,D-Ala10]GnRH) displays a strong affinity for the 
GnRHR.  The GnRH antagonist, SB-75, not only occupies GnRH binding sites, but can 
also down-regulate GnRHR concentration (Halmos et al., 1996).  Halmos and associates 
(1996) treated male rats with a single 100 μg dose of SB-75, which reduced the number 
of binding sites as determined by receptor binding assay.  Using desaturation methods, it 
was reported that the decrease in binding was associated with SB-75 down-regulation of 
GnRHRs and not simply occupancy.  The down-regulation persisted for at least 72 h.       
The antagonist, SB-75, does not, however, have an effect on GnRH II-R signaling 
activity (Neill, 2002).  In male rats, a single treatment of SB-75 decreased membrane 
GnRHR concentration within 2 h following administration.  The maximum effect of SB-
75 was attained by 6 h (83% reduction), and levels of GnRHR were significantly reduced 
for greater than 48 h (Halmos and Schally, 2002).  This is in agreement with a previous 
study in which SB-75 treatment decreased GnRHR levels in male rat anterior pituitary 
membranes by 82% with no effect on affinity (Pinski et al., 1996).  Additionally, 
treatment with SB-75 in castrate male rats caused an 80% reduction in LH levels by 24 h.  
Levels of LH remained low for 72 h, but returned to pre-treatment levels by 96 h post-
treatment (G. Jiang et al., 2001).  Chronically treated animals also had a decline in 
GnRHR concentration with the greatest reduction observed on Day 14 of treatment (86% 
reduction).  The single injection and chronic treatments maximally decreased GnRHR 
mRNA levels nearly 27% and 35%, respectively (Halmos and Schally, 2002).  Halmos 
and Schally also looked at GnRHR numbers in nuclear extracts of the same samples and 
found an opposite effect of SB-75 treatment.  There appears to be an inverse relationship 
between amounts of GnRHR in nuclear and membrane extracts, possibly due to 
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internalization and translocation of bound GnRHRs. Treatment with SB-75 caused 
female rats to remain in a state of perpetual diestrus for the duration of a 30-day 
treatment.  Additionally, LH levels declined by 80%, and there was a decrease in 
estrogen, progesterone and GnRHR over the duration of the treatment (Horvath et al., 
2002).  Horvath and associates (2002) also demonstrated that levels of GnRHR protein 
increased following ovariectomy, but SB-75 treatment for 10 d decreased the elevated 
levels by 84%. 
 In many in vivo experimental studies, endogenous GnRH competes for binding 
with the analogue being tested.  To demonstrate the effectiveness of persistent analogue 
treatment, male rats were treated daily for four weeks with either saline, a GnRH agonist 
([D-Trp6]-GnRH), or a GnRH antagonist (SB-75).  Next, rats were challenged with a 
single intravenous injection of GnRH.  Levels of LH increased within 10 minutes 
following challenge in control and agonist treated groups.  Levels of LH continued to rise 
after 30 minutes in the control animals and, at a significantly reduced rate (~45% 
inhibition), in the agonist-treated group.  Levels of LH released in the SB-75 treated 
group were significantly less than control and agonist-treated groups (~80% inhibition).  
Likewise, levels of GnRHR were reduced in both agonist and SB-75-treated groups by 
68% and 82%, respectively (Pinski et al., 1996).  From these results, it appears that 
chronic administration of a GnRH agonist or antagonist desensitizes gonadotropes to 
GnRH stimulation, via down-regulation of GnRHR. 
  
Gonadotropins and Gonadotropin Subunits 
General.  The gonadotropins are heterodimeric glycoproteins each sharing a  
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common α-subunit; however it is the individual β-subunits that give FSH and LH 
biological specificity.  Secretion of the gonadotropins, FSH and LH, is controlled by 
GnRH.  Pulses of LH are a result of, and mimic, GnRH (Padmanabhan et al., 2003) and 
GnRH is immensely responsible for both basal and pulsatile LH release (Esbenshade et 
al., 1986).  Interestingly, while most GnRH pulses (90% in ovariectomized and 70% in 
luteal phase ewes) produced an FSH pulse, pulses of FSH were also observed in absence 
of a GnRH pulse.  In addition, Padmanabhan and associates found FSH pulses in 
hypothalamo-hypophyseal portal blood that was not associated with GnRH stimulation, 
and that episodic patterns of FSH secretion continued after treatment with a GnRH 
antagonist, suggesting an alternate non-GnRH component of FSH release.     
 
Effect of GnRH Pulsatility.  Frequency of GnRH pulses produces differing 
gonadotropin responses (Jayes et al., 1997).  In GnRH immunized gilts, a high pulse 
frequency (every 30 minutes) of a non-cross-reactive GnRH agonist produced a greater 
response in LH release than FSH.   However, after three days of treatment, both LH and 
FSH had been desensitized to GnRH.  Low frequency (every 180 minutes) pulses of 
GnRH did not increase LH levels, but was at an effective level to maintain FSH 
production.  Further, low frequency pulses of GnRH did not cause the desensitization to 
GnRH by FSH and LH secretion that was observed with high frequency pulsation.  In 
both groups, a bolus injection of GnRH administered on the third day of treatment 
resulted in an inverse relationship between pulse frequencies of GnRH and response to 
the bolus, further showing desensitization in the high pulse group (Jayes et al., 1997).  In 
another study, continuous infusion of GnRH caused an initial increase (2 h) in LH, 
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followed by a gradual decrease to baseline levels (~20 h) in ewes (Nett et al., 1981).  
Levels of FSH initially increased (2 h) during the infusion period but, unlike LH, levels 
of FSH diminished quickly to baseline (5.5 h) followed by a further 70% decrease below 
baseline (14 h).  
Pulse and pattern of GnRH stimulation differentially regulates expression of the  
common α-glycoprotein, and specific FSHβ- and LHβ-subunits (Haisenleder et al., 1991).  
To demonstrate the effect of GnRH pulse frequency on gonadotropin subunit expression, 
gonadotrope-derived LβT2 cells were treated with pulses at 30 minutes and 2 h.  The 
greatest expression of the LHβ-subunit gene was observed at a GnRH pulse frequency of 
every 30 minutes; however the FSHβ-subunit was maximally stimulated at the lower 
pulse frequency of GnRH (2h; Bédécarrats and Kaiser, 2003).  Levels of the α-subunit 
were expressed at all levels with less dependence on GnRH pulse frequency.  
 
Effect of GnRH Receptor on Subunit Expression.  The transcriptional response 
of the gonadotropic subunits due to GnRH stimulus is influenced by the amount of 
GnRHR expressed (Kaiser et al., 1995).  Levels of LHβ- and α-subunit activity were 
increased by GnRH proportionally to the number of GnRHRs.  In contrast, the FSHβ-
subunit was most favorably stimulated at low levels of GnRHR gene expression.  
Differential regulation of the FSHβ- and LHβ-subunits was also observed in LβT2 cells 
where an increase in GnRHR levels specifically inhibited FSHβ-subunit gene promoter 
stimulation (Bédécarrats and Kaiser, 2003).  This suggests that regulation of the 
gonadotropin subunits by GnRH may differ at low vs. high levels of GnRHR.  Kaiser and 
associates (1995) suggested that factors, such as GnRH pulse frequency, may regulate the 
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amount of GnRHR expressed on the gonadotrope cell surface, which in turn regulates 
expression of the gonadotropic subunits, potentially through different signaling pathways.  
At low GnRHR numbers, all three gonadotropin subunit genes are expressed.  However, 
at high levels, an inhibitory effect is seen on FSHβ-subunit gene expression only, 
substantiating the theory that the subunits may be regulated by different signal 
transduction pathways. 
Mutations in the human GnRHR cause alterations in expression of the 
gonadotropin subunits.  Stimulation with GnRH resulted in an 8-fold reduction in LHβ-
subunit gene promoter activity when mutations occurred at positions 106 (Arg for Gln in 
first extracellular loop) and 262 (Gln for Arg in third intracellular domain) of the human 
GnRHR (Bedecarrats et al., 2003).  The mutations caused a decrease in GnRH 
responsiveness of FSHβ-subunit gene promoter activity by 14 and 15-fold, and α-subunit 
gene promoter activity by 3.8 and 10.6-fold for the 106 and 262 mutations, respectively.  
This is interesting considering the effects on FSHβ- and LHβ-subunit gene expression of 
the mutations are fairly equal, whereas the two mutations cause differential effects to α-
subunit expression.  The differential effects of the mutations are also observed in GnRHR 
gene promoter activity with the 106 and 262 mutations decreasing GnRHR gene 
promoter activity by 2.2- and 3.7-fold, respectively.  Bedecarrats and associates (2003) 
also observed that the wild-type FSHβ-subunit gene had a greater sensitivity to GnRH 
stimulation than the LHβ- or α-subunit genes, suggesting the FSHβ-subunit gene is more 
sensitive to intracellular signaling, or is regulated by a different signaling pathway.  
There was also a decrease in sensitivity of the ERK pathway in the mutated GnRHR, with 
a greater effect of the 262 mutation.  Evidence for stimulation of different signaling 
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pathways by GnRH is also indicated by the differential effects of GnRH on both the α-
subunit and GnRHR genes.  Though there were differing responses to GnRH stimulation 
by the α-subunit and GnRHR genes, levels of inositol phosphate were similarly decreased 
in both mutant receptors, further suggesting the action of multiple pathways.      
 
Differential Regulation of Gonadotropin Subunits.  Using cultured α-T3 cells,  
Chedrese and associates (1994) demonstrated a stimulatory effect of GnRH on 
transcription of the glycoprotein hormone α-subunit gene, as well as mRNA stability.    
Interestingly, GnRH caused a temporary increase in transcription, but levels of α-subunit 
mRNA remained stable during the time of transcriptional decline.  In the absence of 
GnRH or with the addition of the GnRH antagonist, antide, levels of α-subunit mRNA 
declined rapidly.  It was determined that in the presence of GnRH, the half-life of α-
subunit mRNA increases 6.7-fold (Chadrese et al., 1994).  This demonstrates that the 
presence of GnRH not only increases the amount of α-subunit gene transcription but also 
plays a part in decreased degradation of α-subunit mRNA.  
To further substantiate differential regulation of gonadotropin subunit genes, 
levels of α- and LHβ-subunit mRNA in the rat did not increase significantly until Day 3 
following ovariectomy, then continued to rise through Day 7 (Burger et al., 2001).  In 
contrast, levels of FSHβ-subunit gene expression were elevated above starting levels by 
12 h following ovariectomy, with another significant increase by Day 3.  Serum levels of 
FSH and LH followed the pattern of their respective subunits.  Treatment with a GnRH 
antagonist eliminated the increase in α-glycoprotein and LHβ-subunit mRNA, and 
decreased, but did not abolish, the increase seen in FSHβ-subunit gene expression  
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following ovariectomy.   
In addition to regulation by GnRH, the FSHβ-subunit gene is positively regulated 
by activin (Weiss et al., 1992), while steroids have a negative action on expression.  
Further, treatment with an inhibin antagonist had no effect on LHβ, but caused an 
increase in FSHβ mRNA levels 12 h following ovariectomy, suggesting that factors other 
than GnRHR also have an effect on the subunit genes.  This differential regulation of the 
gonadotropic subunits creates the potential for differential secretion of the respective 
gonadotropins.    
 
Role of Subunits in Secretion of Gonadotropins.  Luteinizing hormone appears 
to be stored intracellularly and secreted in a regulated manner (facilitating the 
preovulatory LH surge), while FSH is released in a constitutive manner (Muyan et al., 
1994).  Brown and associates (2001) conducted an experiment to determine if expression 
of FSHβ- and LHβ-subunit genes contributed to the differential patterns of FSH and LH 
storage and secretion.  This was accomplished by creating transgenic mice with a 
truncated ovine FSHβ-subunit gene encoding an mRNA lacking the 3’ untranslated 
region and driven by the ovine LHβ-subunit gene promoter.  Two lines of mice were used 
in this study, an FSHβ deficient (dFSH) line and a line deficient in both FSH and inhibin 
(dFI).  Both lines of mice were infertile.  Expression patterns of ovine FSHβ mRNA were 
similar to the murine LHβ, but not murine FSHβ.  Although the expression profile of 
FSHβ mRNA was manipulated to mimic that of LHβ, only increased levels of FSH were 
observed, with no changes in storage properties.  This indicates that regardless of 
synthesis, post-translational modifications promote the storage of LH and release of FSH 
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from the anterior pituitary gland.  Substitution of the LHβ-subunit promoter for the 
FSHβ-subunit promoter diminished the transcriptional response to steroids and removed 
inhibin responsiveness.  This suggests there are elements within the promoter region of 
the FSHβ gene that are responsible for regulating the level of FSH synthesis.  There was 
an increased ovulation rate in the dFSH line that was not observed in the dFI line.  The 
increase ovulation rate was attributed to differential post-translational glycosylation of 
FSH between the dFSH line, which had higher glycosylation levels, and the dFI line.  The 
glycosylation in the dFSH line may cause the half-life of FSH to increase, exposing the 
ovary to higher levels of FSH for a longer period of time.  The increased ovulation rate 
could be due to increased follicular recruitment or decreased follicle atresia. 
 
Hormonal Influence on GnRH Receptor, Gonadotropins and Their Subunits 
Estradiol-17β.  Estradiol-17β from preovulatory follicles stimulates the LH 
surge, as well as the onset of estrus, which in turn stimulates the final maturation and 
ovulation of follicles in the pig (Van de Wiel et al., 1981).  It appears that stimulation of 
the LH surge occurs as estrogen reaches and maintains a particular threshold level.  Britt 
and associates (1991) hypothesized that estradiol-17β blocks endogenous GnRH 
secretion through negative feedback allowing LH to accumulate in the anterior pituitary 
until a time that positive GnRH feedback causes the LH surge to occur.  Initially, it 
appears estradiol reduces responsiveness of GnRHRs to GnRH leading to a reduction in 
secretion of GnRH for a period of time.  This is followed by positive feedback from 
pulses of GnRH as estradiol-17β levels decline.  The ensuing LH surge is proportional to 
the amount of GnRH stimulation on the anterior pituitary gland.  Thus, negative 
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inhibition by estradiol-17β allows LH stores to build within the anterior pituitary 
facilitating the preovulatory LH surge when GnRH stimulation is returned. 
 Follicle stimulating hormone appears to act in an opposite fashion as estradiol-
17β.  When levels of FSH are increased, such as the time prior to the preovulatory LH 
surge and following ovulation, estradiol-17β levels decrease.  As FSH levels begin to 
decrease in the pig on Day 3 following the LH surge, estradiol-17β levels begin to rise.  
Increased estradiol-17β secretion during follicle maturation coincided with a decrease in 
FSH secretion in gilts (Guthrie and Bolt, 1985).  In cows, prolonged exposure to 
estradiol-17β stimulated primordial follicles to be activated (Cushman et al., 2001).  As 
follicles begin to grow following FSH exposure, estradiol-17β production in those 
follicles increases, suppressing FSH and preventing further follicle growth (Van De Wiel 
et al., 1981).  In a study by Baratta et al. (2001), a parallel decline in mRNA for FSHβ 
and activin βB was observed in ovine pituitary cells treated with estradiol-17β.  These 
data suggest that the decline in FSH coinciding with increased estradiol-17β is caused, in 
part, by inhibition of activin βB production.  Consistent with this, a putative estrogen 
response element has been identified in the 3’-untranslated region of the human activin 
βB gene (Mason et al., 1989).       
 Estradiol-17β also has an effect on GnRHR regulation.  Estradiol-17β functions to 
increase the number of GnRHRs through actions at the anterior pituitary gland in a time 
and dose dependent manner (Gregg et al., 1990).  Clayton et al. (1980) hypothesized that 
cyclic levels of estradiol-17β stimulated GnRH release from the hypothalamus, inducing 
GnRHR up-regulation as well as a subsequent hypothalamic GnRH release.  In ovine 
pituitary cultures, GnRHR levels increased 30 to 40 fold following a 48-hour estradiol-
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17β treatment (Laws et al., 1990).  An increase in number of GnRHRs was also seen in 
ovariectomized cattle treated with estradiol-17β (Looper et al., 2003).  In rats, there is an 
increase in GnRHR mRNA after estradiol-17β treatment which appears to occur due to 
an increased number of gonadotropes expressing GnRHR mRNA, as determined by in 
situ hybridization (Quiñones-Jenab et al., 1996).  A study of ovine pituitary cultures 
indicated similar results, as estradiol-17β treatment alone increased GnRHR mRNA 
190% over controls and this increased to 400% when treated in combination with inhibin 
(Wu et al., 1994).   
In contrast, Cheon and co-workers (2000) found that estrogen had no effect on 
basal expression of GnRHR mRNA in primary rat pituitary cell cultures.  When treated 
with GnRH, there was homologous up-regulation, but no additional increase with 
estradiol-17β treatment.  Addition of progesterone diminished the upregulation by GnRH 
and coincubation with estradiol-17β did not rescue the loss.  Kakar et al. (1994) found 
increased GnRHR mRNA levels in rats 28 days after ovariectomy.  Upon estradiol-17β 
treatment, the level of GnRHR mRNA decreased, indicating a negative relationship 
between estradiol-17β and GnRHR gene expression.  Quiñones-Jenab (1996) postulated 
that prolonged ovariectomy may stifle the effect of estradiol-17β on GnRHR stimulation 
following long periods of absence.  This is further substantiated by work in gilts (Stickan 
et al., 1999), where 100 day post-ovariectomy gilts did not respond to estradiol-17β 
treatment.  It has also been noted in wethers that under physiological concentrations, 
estradiol-17β can increase steady state levels of GnRHR mRNA, whereas chronic levels 
of estradiol-17β may desensitize the pituitary and cause the opposite effect (Adams et al., 
1996).               
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In ovariectomized ewes subjected to hypothalamic-pituitary disconnection (HPD), 
treatment with estradiol-17β elicited no effect on LH, whereas intact control animals 
exhibited LH patterns that resembled the pre-ovulatory LH surge (Gregg et al., 1989).  In 
the study by Gregg and associates (1989), estradiol-17β stimulated an increase in the 
number of GnRHR in the HPD group, increasing 2-fold over control animals, without 
hypothalamic input in the form of GnRH.  Thus, estradiol-17β can increase the number of 
GnRHRs on gonadotropes by acting on the hypothalamus to increase GnRH secretion.  In 
addition, estradiol-17β can stimulate the anterior pituitary gland to increase the number of 
GnRHRs, thereby increasing sensitivity to GnRH. 
 
Progesterone.  Progesterone, released from luteal cells provides strong negative 
feedback at the level of the hypothalamus to reduce GnRH secretion (Senger, 1999) and 
GnRHR expression (Turzillo et al., 1994).  Progesterone decreased homologous up-
regulation of GnRHR mRNA expression in rat pituitary cell cultures (Cheon et al., 2000).  
In ewes, an increase in GnRH binding to GnRHR was not observed until progesterone 
levels had reached baseline (Crowder and Nett, 1984).  Female rats had a decrease in 
GnRHR levels due to progesterone present during proestrus (Witcher et al., 1984).  In 
another study with sheep, an increase in GnRHR number appeared to require removal of 
negative feedback by progesterone and stimulation by estradiol-17β (Kirkpatrick et al., 
1998).  Turzillo et al. (1994) found that declining progesterone levels were followed by 
an increase in the number of GnRHR, but occurred before levels of estradiol-17β had 
begun to increase.  This suggests that estradiol-17β may increase GnRH binding sites 
during proestrus, but a decrease in progesterone levels may be needed before the increase  
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can occur.   
Gilts fed a progesterone agonist developed a pool of medium-sized follicles which 
failed to mature, preventing estrous behavior and blocking the preovulatory LH surge 
(Guthrie and Bolt, 1985).  Female mice lacking the hepatic lipase gene had a reduction in 
litter size as a result of decreased ovulation rate due to reduction in progesterone 
production (Wade et al., 2002).  Hepatic lipase provides cholesterol substrate for 
steroidogenesis.  Wade and associates (2002) postulated that the reduction in 
progesterone production due to lack of substrate reduced the amount of follicles that 
underwent final maturation.  This was apparently due to a high number of non-ovulatory 
follicles present following hCG stimulation. 
In addition to its effects on GnRHR regulation, progesterone increased levels of 
mRNA for LHβ in cultured rat pituitary cells (Park et al., 1996), but had no effect on 
mRNA levels for the other gonadotropic subunits (Looper et al., 2003).  The increase in 
LHβ mRNA levels in rat pituitary cell cultures was caused by progesterone suppression 
of RNA degradation (Park et al., 1996).    When treated with actinomycin D, an inhibitor 
of transcription, levels of LHβ mRNA decreased by 30% compared to controls.  Cells 
treated with progesterone alone or progesterone and estrogen in combination were able to 
suppress the degradation of LHβ mRNA, indicating that progesterone is capable of 
modulating LHβ turnover rate. 
 
Inhibin.  Inhibin, produced and released by granulosa cells of the follicle, acts on 
the anterior pituitary gland to inhibit FSH secretion.  In this manner of negative feedback, 
inhibin regulates the levels of circulating FSH.  Basal release of FSH was suppressed by 
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inhibin but had no effect on LH release in rat primary pituitary cell cultures (Braden et 
al., 1990).  Inhibin did not affect the basal rate of GnRHR synthesis, but did interfere 
with the stimulatory effect of GnRH on GnRHR synthesis.    
Medan et al. (2003a) demonstrated that goats could be superovulated through 
passive immunization to inhibin.  Upon immunization, levels of plasma FSH increased 
whereas LH levels remained unchanged.  Animals passively immunized against inhibin 
also had an earlier preovulatory FSH surge with a higher peak when compared to 
controls.  It appears that, after negative feedback from inhibin is eliminated, the increased 
level of FSH present stimulates the development of a new cohort of small follicles.  
Increased levels of FSH influenced follicular recruitment and development, resulting in 
growth of several more follicles and a subsequent increase in ovulation rate.  In another 
study by Medan et al. (2003), active immunization to inhibin resulted in a positive 
correlation between levels of inhibin antibody titres and ovulation rate.   
Inhibin immunization resulted in an increased number of developing and ovulated 
follicles in immature, 26-day-old mice compared to adult cyclic mice.  Decreased levels 
of other negative regulatory factors in immature mice that influence gonadotropin release, 
such as estradiol-17β, could provide an explanation for the increased number of follicles.  
This finding indicates that immature mice have a functional negative feedback control 
system in place to regulate pituitary FSH secretion by inhibin (H. Wang et al., 2001).  
However, as FSH was not measured, it is not possible to determine if increased levels of 
FSH were responsible for the increase in the number of  
follicles observed in immature mice.  
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Homologous Regulation of the GnRH Receptor 
 GnRH Effects on GnRH Receptor Numbers.  In vitro studies have 
demonstrated that GnRH can alter the number of pituitary GnRHRs (Loumaye and Catt, 
1982).  Changes in the number of GnRHRs can cause changes in pituitary responsiveness 
to GnRH (Clayton et al., 1980).  Cultured rat pituitary cells treated with GnRH had a 
40% decrease in binding capacity in the first hour of treatment which returned to baseline 
by 4 h, followed by an increase in binding sites after 6 h (Loumaye and Catt, 1983).  To 
determine what caused the increase in binding sites following down-regulation, the cells 
were treated with cycloheximide, a protein synthesis inhibitor.  Treatment prevented the 
increase in binding sites as seen in the prior experiment, indicating that synthesis of new 
GnRHR was needed to increase binding sites following desensitization.  In another study, 
continuous infusion of GnRH caused an initial increase in the number of GnRHRs after 4 
h, followed by a decrease to 70% (12 h) and 50% (24 h) of the pre-treatment value (Nett 
et al., 1981).  Nett and associates (1981) postulated that the decrease in GnRHR numbers 
was an inert system to compensate for an affluence of GnRH.       
 
Transcriptional vs. Translational Regulation.  Homologous regulation of 
GnRHRs by GnRH could be controlled by changes in mRNA levels (transcriptional) or 
amount of protein being produced (translational).  Cheon and associates (2000a) further 
explored GnRHR autoregulation using both transcriptional and translational inhibitors in 
pituitary cell cultures to determine: 1) if homologous up-regulation requires new RNA 
synthesis, 2) if homologous up-regulation requires new protein synthesis, and 3) the 
effect of GnRH on basal turnover of GnRHR mRNA.  Adding GnRH to pituitary cells 
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caused an increase in both GnRHR mRNA and LH levels after 6 h.  The transcriptional 
inhibitor, actinomycin D, had no effect on the level of GnRHR mRNA or LH production.  
However, when actinomycin D and GnRH were added simultaneously, the GnRH 
induced increase in GnRHR mRNA was lost and LH levels were also reduced.  Using an 
inhibitor to protein synthesis, cycloheximide, Cheon and co-workers (2000a) reported 
there was no effect on basal expression or the GnRH-induced increase in GnRHR mRNA 
levels.  Luteinizing hormone levels were similar to those in pituitary cells treated with 
actinomycin D.  Thus, it appears that homologous regulation of the GnRHR gene occurs 
at transcription.   
Similarly, female rats receiving a sustained-release of a GnRH antagonist had a 
reduction in GnRHR mRNA over a four week period, and the level of GnRHR mRNA 
was still significantly lowered at eight weeks (Sakakibara et al., 1996).  Treatment with 
GnRH or a GnRH agonist caused a biphasic response in GnRHR mRNA in human 
granulosa-luteal cells; low concentrations caused up-regulation whereas high 
concentrations resulted in down-regulation (Kang et al., 2001).  In the ewe, numbers of 
GnRHR increased following an increase in GnRHR mRNA (Turzillo et al., 1994).  In 
αT3-1 cells, exposure to GnRH reduced the amount of GnRHRs, as well as level of 
GnRHR mRNA in a time- and dose-dependent manner (Mason et al., 1994).  Northern 
blot analysis revealed that treatment with D-Ala6-GnRH stimulated mouse GnRHR 
mRNA.  Maximal stimulation was achieved at 4 h in α-T3-1 cells, after which levels of 
GnRHR mRNA began to decline (Norwitz et al., 1999).     
In contrast to the studies described above, Tsutsumi and co-workers (1993) 
discovered that, with exposure to physiological levels of GnRH in a gonadotrope-derived 
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cell line, the number of GnRHRs increased without a corresponding change in mRNA 
levels.  Thus, it did not appear that regulation of the GnRHR involved changes in gene 
transcription, but rather augmented translational mechanisms.  When GnRH was added to 
primary pituitary cultures, there were trends toward suppression of GnRHR mRNA 
turnover by increasing its half-life, as well as an increased stability of pre-existing mRNA 
(Cheon et al., 2000a).  Thus, stability of pre-existing mRNA may be important in the 
regulation of steady-state levels.  However, homologous up-regulation of GnRHR occurs 
through transcriptional activation of the GnRHR gene rather than enhancement of the 
stability of pre-existing mRNA.     
 
Cell Signaling Pathways Involved in Transcriptional Regulation of the 
GnRH Receptor Gene.  It is known that GnRH binding to its receptor in gonadotropes 
stimulates cell signaling through multiple pathways, however two pathways have 
primarily been investigated.  The first pathway results in phospholipase C (PLC) 
generation of diacyl glycerol (DAG) and inositol triphosphate (IP3), which activates 
protein kinase C (PKC).  The second cascade involved in GnRH signaling results in the 
stimulation of cyclic andenosine monophosphate (cAMP).   
 
Cell Signaling via Protein Kinase C.  The αT3-1 cell line is a mouse 
gonadotrope-derived cell line that contains a lower number of GnRHR than gonadotropes 
themselves and expresses GnRHR and the gonadotropin α-subunit (Kaiser et al., 1997).  
Responsiveness of the GnRHR gene promoter to GnRH in this cell line is mediated 
through activation of the PKC cellular signaling pathway.  Activated PKC then signals 
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through stimulation of the mitogen-activated protein kinase (MAPK) pathway which 
ultimately cause an activating protein-1 (AP-1) complex to bind an element located 
between -336 and -330 of the mouse GnRHR gene promoter (White et al., 1999).  Others 
have identified the same AP-1 binding site as a critical element for GnRH responsiveness 
of the mouse GnRHR gene promoter in a position between -276 and -269 bp upstream of 
the transcriptional start site, termed the sequence underlying responsiveness to GnRH-2 
(SURG-2; Norwitz et al., 1999).  Another element, SURG-1 (-292 to -285), was found to 
be an enhancer element.  Thus, SURG-2 is critical for responsiveness of the mouse 
GnRHR gene to GnRH, but SURG-1 is necessary for the maximal response to GnRH 
(Norwitz et al., 1999).  In addition, the regulation of GnRH at the AP-1 site is associated 
with JunD and FosB binding, as well as the c-Jun N-terminal kinase (JNK) signaling 
cascade (Ellsworth et al., 2003).  It is also interesting to note that changes in c-jun mRNA 
levels closely resemble those of GnRHR mRNA in the ewe (Padmanabhan et al., 1995). 
Individually buserelin, a GnRH agonist, and phorbol 12-myristate 13-acetate 
(PMA), an activator of PKC, stimulated GnRHR gene promoter activity in GGH3 cells 
(somatolactotrope cells stably transfected with the GnRHR gene; Kaiser et al., 1994) 
transfected with a reporter vector containing 1226 bp of the mouse GnRHR gene 
promoter, with the greatest stimulation from buserelin (Linn and Conn, 1999).  However, 
addition of PMA to buserelin-treated cells did not enhance GnRHR promoter activity.  
Inhibition of the PKC pathway caused a decrease in basal levels and abolished 
stimulation of the GnRHR gene promoter by both buserelin and PMA.  Continuous 
stimulation with PMA desensitized subsequent stimulation by buserelin and PMA, but 
had no effect on cAMP, suggesting that a PKC-dependent pathway is involved in GnRH  
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regulation of GnRHR gene promoter activity. 
    
Cell Signaling via Protein Kinase A.  Treatment of αT3-1 cells transfected with 
the full length 5’ flanking region from the human GnRHR gene promoter with forskolin 
induced a substantial increase in activation of the GnRHR gene promoter in a time- and 
dose-dependent manner (Cheng et al., 2001).  Forskolin causes increases in intracellular 
cAMP production by adenylate cyclase activation.  To further substantiate the cAMP 
effect, treatment with cholera toxin (stimulates continuous adenylate cyclase activation) 
and a cAMP agonist mimicked the stimulatory increase in GnRHR gene promoter 
activity.  Inhibition of protein kinase A (PKA) and adenylate cyclase reduced forskolin 
stimulation of GnRHR gene expression (Cheng et al., 2001).  This is in contrast to other 
reports in which forskolin had no stimulatory effects on mouse GnRHR expression in 
αT3-1 cells (Norwitz et al., 1999; White et al., 1999).    
Cheng and associates (2001) also found potential AP-1/cAMP Response Element 
Binding protein (CREB) binding sites (hGR-AP/cAMP Response Element-1 (CRE-1) 
and hGR-AP/CRE-2) between -407 and -167 of the human GnRHR gene promoter.  
Mutations of each site individually caused a reduction in forskolin-induced stimulation.  
Interestingly, mutation of hGR-AP/CRE-1 caused a decrease in basal GnRHR gene 
expression, while hGR-AP/CRE-2 causes an increase.  Double mutation of both sites 
caused a further reduction of forskolin stimulation, but had no effect on basal expression.   
Using gel mobility shift assays, it was discovered that the first site binds only CREB, 
whereas the second site binds AP-1 before, but CREB following, forskolin treatment.  It 
is presumed that forskolin activation increases the amount of CREB, allowing it to 
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compete away AP-1 binding.  This suggests that AP-1 suppresses basal activity of the 
GnRHR gene promoter and binding of CREB changes the inhibitory regulation to a 
stimulatory response. 
Cholera toxin or cAMP treatment of GGH3 cells transfected with reporter vectors 
containing 1226 bp of the murine GnRHR gene promoter stimulated GnRHR promoter 
activity.  Treatment with cAMP also enhanced the duration of buserelin stimulation of 
GnRHR gene promoter activity (Lin and Conn, 1998).  Treatment with a cAMP inhibitor 
had no effect on basal promoter activity, but reduced the level of buserelin activation.  
Thus, it appears that GnRH stimulates cAMP production and also activates transcription 
of the GnRHR gene in part through stimulation of the cAMP signal transduction cascade 
in GGH3 cells.   
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CHAPTER III 
 
 
General Materials and Methods 
 
Animals   
All animal procedures were conducted according to the University of Nebraska 
Institutional Animal Care and Use of Committee.  White crossbred gilts of both the Index 
and Control lines (Generation 23) were transported to the UNL Animal Science Building 
from the University of Nebraska Agricultural Research and Development Center (ARDC) 
Swine Unit in Mead, Nebraska.  Gilts of the Meishan breed were transported to the 
Animal Science Building from the United States Department of Agriculture, Roman L. 
Hruska U.S. Meat Animal Research Center in Clay Center, Nebraska.  Gilts were housed 
in pens with a minimum of 8 square feet of floor space, 4 pounds of feed per day and 
water available ad libitum.  Gilts of the Index and Control lines were detected for estrus 
beginning at 155 days of age, whereas estrous detection began at 95 days of age for 
Meishan females.  Upon completion of the third (Index and Control) or sixth (Meishan) 
estrus, ten gilts from the Index and Control lines, and 12 Meishan gilts (Table 3.1) were 
ovariectomized during the luteal phase (Day 5 through 15 of the estrous cycle).  Based on 
a preliminary study in our laboratory and previous reports (Christenson et al., 1993; 
Hunter et al., 1993), Meishan gilts do not exhibit an increased ovulation rate following 
three estrous cycles when compared to gilts of occidental breeds.  Thus, an additional 
three estrous cycles were allowed for Meishan females to increase ovulation rate to a 
level above that of control gilts.  Moreover, ovulation rate in Meishan females continues  
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TABLE 3.1. EXPERIMENTAL DESIGN 
 Breed 
Treatment Control Index Meishan 
Control n=5 n=5 n=6 
SB-75 n=5 n=5 n=6 
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to increase with age at a greater rate than observed in occidental breeds (Christenson et 
al., 1993). 
 
Surgical Procedures   
Ovariectomies were performed in the surgical facility at the Animal Science 
Building using procedures approved by the Institutional Animal Care and Use 
Committee.  Animals were anesthetized with 6 ml of a mixture of telazol, atropine, 
rompun and ketamine (TARK) administered intramuscularly in the neck followed by 4 
ml delivered intravenously in the ear.  The composition of TARK and the time and 
amount of other drugs administered for surgical procedures are presented in Table 3.2. 
Once anesthetized, the incision site was prepared for surgery by washing with 
warm water and removing hair.  The site was then disinfected with three betadine washes 
and 70% isopropyl rubbing alcohol, which also aided in drying.  Feet were covered with 
plastic O.B. gloves and restrained with rope.  Nose tubes were inserted into each nostril 
for administration of halothane and oxygen (3.5% and 0.7 L/min, respectively) 
throughout the surgery.  Gilts were given 3 ml of Polyflex (8.8 mg/kg; Fort Dodge 
Animal Health, Fort Dodge, IA) and 2 ml of Banamine (2 mg/kg; Schering-Plough 
Animal Health Corp., Union, NJ) following ovariectomy and one day post-surgery (Table 
3.2). 
Entry into the abdomen was facilitated by an incision into the skin at the midline.  
Using gauze, the underlying fat was bluntly dissected revealing the linea alba.  Next, an 
incision was made through the abdominal wall at the linea alba.  Upon entry into the 
body cavity, one uterine horn was externalized to expose the ovary while the other  
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TABLE 3.2. COMPOSITION OF TARK ANESTHETIC AND  DOSE AND TIME OF  
         DRUG DELIVERY FOR SURGICAL PROCEDURES 
 
Drug Route *Dose (mg/kg) Special Instructions 
Telazol I.M. 0.8 
Pre-operative in neck behind ear 
Atropine I.M. 0.2 
Rompun I.M. 0.8 
Ketamine I.M. 3.1 
Telazol I.V. 0.5 
Approximately 10 minutes post 
I.M. in ear vein 
Atropine I.V. 0.1 
Rompun I.V. 0.5 
Ketamine I.V. 2.1 
Halothane Inhalation 3.5% During Surgery 
Ampicillin 
(Polyflex) I.M. 8.8 Following Surgery + 1 day 
Banamine I.M. 2.0 Following Surgery + 1 day 
*Based on average body weight (114 kg or 250 lbs) 
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remained inside the body cavity to prevent drying, which may cause adhesions.  The 
reproductive tract was rehydrated with 5% glycerol saline on tissue that appeared 
dehydrated.  The ovary was located and grasped firmly, moving the fimbria away from 
the ovarian body.  Next, it was clamped between the ovary and the bursa of the oviduct 
using a large, curved Rochester-Carmalt clamp.  The clamp was raised by the surgical 
assistant, and the blunt end of a large, one half circle, taper point needle threaded with #2 
catgut was pushed through the end of the hilus with care made to avoid any blood 
vessels.  The catgut was then cut into two pieces and the suture was tied off by hand on 
each side with a double knot, followed by three single knots.  Each suture tied off 
approximately one half of the hilus.  Then, each suture was tied to circumnavigate the 
hilus, thus tying off the entire hilus.  The ovary was removed by cutting across the top of 
the clamp, between the clamp and ovary, with a scalpel blade.  Corpora lutea (CL) were 
counted to determine ovulation rate and the ovary was placed in a 50-ml conical tube on 
ice for later analysis.  With the ovary removed, the clamp was relaxed to determine the 
presence of bleeding.  If no bleeding was found, the horn was rehydrated with 5% 
glycerol saline and returned to the body cavity.  The remaining ovary was removed in a 
similar manner.  When both ovaries had been removed, the body wall was closed using 
an interrupted stitch with #2 catgut.  The skin was then loosely sutured with #0 catgut 
using a continuous mattress stitch.  Animals were allowed to recover overnight and 
returned to housing pens in the animal facility. 
 
Treatments   
Approximately three weeks (18-22 days) after ovariectomy, gilts from each line  
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were randomly assigned to treatment groups.  Animals from each line received an 
injection of either the specific GnRH antagonist, SB-75 (10 μg biologically active 
compound per kg of body weight; UNL Protein Core Facility), or vehicle (0.9% saline) at 
60, 36 and 12 hours prior to sacrifice.  A timeline of experimental treatments is presented 
in Figure 3.1. 
 
Serum and Tissue Collection   
Blood samples were collected via jugular venopuncture prior to ovariectomy and 
the first injection.  Gilts from the Index, Control, and Meishan lines were transported to 
the UNL abattoir the morning of sacrifice.  Animals were rendered unconscious by 
electrical stunning followed by exsanguination.  At this time, a blood sample and the 
head were collected.  The top of the skull was removed using a bone saw.  Next, the 
pituitary gland was removed and transferred to a sterile Petri dish using RNase free 
utensils.  The anterior and posterior pituitaries were separated and the anterior pituitary 
was divided into quarters.  One quarter was placed in a sterile 2-ml cryovial and snap 
frozen in liquid nitrogen.  The remaining three quarters of the pituitary (approximately 65 
mg of tissue/quarter) were placed in RNAlater (Ambion, Inc., Austin, TX) and kept on 
ice for later RNA extraction. 
 
Radioimmunoassay   
Following collection, blood samples were allowed to coagulate at 4°C for 24 
hours at which time they were centrifuged at 1200 x g for 20 minutes at 4°C.  Serum was 
stored at -20°C until needed.   
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Figure 3.1. Timeline of ovariectomy, treatments, blood sampling and tissue collection. 
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LH.  Iodination grade porcine LH (AFP11043B, A.F. Parlow, National Hormone 
and Peptide Program, Torrance, CA) was radioactively labeled with Na-125I using the 
“controlled” chloramine-T method (Proudman and Wentworth, 1978).  Chloramine-T 
oxidizes 125I from an anionic to a cationic form (Parker, 1981).  The cationic form of 125I 
is then able to react with the aromatic ring of tyrosine residues in porcine LH.  Briefly, 20 
μl of 0.25M NaPO4 was added to 2.5 μg porcine LH in PBS buffer (pH 7.4).  To this, 
0.152 nmol of Na-125I was added followed by 5.5 μg of Chloramine-T (rate limiting 
amount).  The reaction was allowed to proceed with intermittent gentle mixing for 5 
minutes, at which time 100 μl of Stop/Transfer solution (1% potassium iodide, 0.01% 
bromophenol blue, 16% sucrose in 0.05M sodium phosphate buffer, pH 7.4) was added.  
Finally, 200 μl of 25% BSA was added and the mixture was loaded onto a QAE 
Sephadex 25 column (0.7 x 15 cm column packed with QAE Sephadex 25, equilibrated 
with 2 ml of 2% BSA and flushed with 20 ml of 0.05 sodium phosphate buffer, pH 7.4).  
Fractions of 0.5 ml were collected into 13 x 100 mm glass test tubes containing 1.5 ml of 
PBS-0.1% gel (0.14M NaCl, 0.01M NaH2PO4, 0.001M Na2H2PO4, 0.1% NaN3, 0.1% 
gelatin).  Fractions were assessed by counting 10 μl of each for radioactivity using an 
APEX Automatic Gamma Counter (ICN Micromedic Systems, Horsham, PA).  The first 
three fractions with significant counts were used to set a binding check (typically 
fractions 6-8).  The amount of each fraction needed to achieve 18,000 cpm/100 μl was 
determined.  Next, calculations were performed to make primary and secondary antibody 
solutions.  The primary antibody was rabbit anti-porcine LH (A.F. Parlow, National 
Hormone and Peptide Program, Torrance, CA) and stored at a 1:50 dilution.  A working 
dilution of 1:210,000 was utilized for the assays.  The secondary antibody was donkey  
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anti-rabbit gamma globulin (dARGG; Fitzgerald Industries, Concord, MA) with a 
working solution of 10.5% dARGG, 0.5% normal rabbit serum (Pel-Freez Biologicals, 
Rogers, AR) and 89% PBS-0.1% gel.  For each fraction, tubes to determine total counts 
(TC), non-specific binding (NSB) and specific binding (Bø) were labeled and prepared 
(Table 3.3).  Each of the TC tubes contained only 100 μl 125I-pLH at approximately 
18,000 cpm/100 μl of their respective fraction.  The NSB tubes contained 600 μl of PBS-
0.1% gel and 100 μl 125I-pLH.  The Bø tubes contained 500 μl of PBS-0.1% gel, 100 μl 
125I-pLH, and 100 μl primary antibody.  Tubes were allowed to incubate at room 
temperature overnight (approximately 14 hours).  The secondary antibody was prepared 
and allowed to precipitate overnight at room temperature.  The following morning, the 
secondary antibody was centrifuged at 1500 x g for 30 minutes. The supernatant was 
poured off and the pellet resuspended in the original volume of PBS-0.1% gel.  To each 
of the NSB and Bø tubes, 100 μl of resuspended secondary antibody was added and the 
mixture was allowed to incubate 1 hour at room temperature. Following incubation, 1 ml 
of ice cold PBS buffer (pH 7.4) was added to the NSB and Bø tubes.  The tubes were 
then centrifuged at 2280 x g for 45 minutes at 4°C.  Following centrifugation, the 
supernatant was poured off and the tubes were counted for radioactivity.  Binding activity 
was determined by the equation:  
((Bø -NSB)/(TC))*100 = % binding 
 Serum levels of LH were measured using a double antibody immunoprecipitation 
method adapted from Niswender et al. (1970).  Levels of LH were determined using an 
antiserum directed against porcine LH (Lot# AFP15103194Rb, A.F. Parlow), highly 
purified, iodinated porcine LH as labeled hormone, and a standard prepared from  
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TABLE 3.3.  TUBE COMPONENTS FOR PORCINE LH RADIOIMMUNOASSAY 
 
Tube PBS-0.1% gel buffer 
125I Primary antibody 
Standard 
or 
Sample  
Secondary 
antibody 
TC --- 100 μl --- --- --- 
NSB 600 μl 100 μl --- --- 100 μl 
Bø 500 μl 100 μl 100 μl --- 100 μl 
Standard 400 μl 100 μl 100 μl 100 μl 100 μl 
Unknown 300 μl 100 μl 100 μl 200 μl 100 μl 
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AFP11043B (A.F. Parlow).  The assay for porcine LH was validated as follows.  Serial 
dilutions of two independent porcine serum samples were assayed at volumes ranging 
from 25 to 400 μl.  Assay determinations of these dilutions from each of the two 
independent samples were highly correlated (r = 0.95).  Parallelism was determined using 
the Allfit program (DeLean et al., 1978).  Slopes of plasma dilutions and the standard 
curve were not significantly different (P > 0.40).     
Assays were performed using the fraction with the highest binding from the 
binding check.  Prior to each assay, a protocol sheet was prepared that identified the tube 
number pertaining to each sample.  The TC, NSB and Bø were prepared as previously 
described.  The standard curve consisted of a porcine LH standard at concentrations of 
0.0312, 0.0625, 0.125, 0.25, 0.5, 1.0, 2.0, 3.5 and 5.0 ng/ml.  The assay also contained 
controls of low and high LH serum, as well as pooled serum used to determine intraassay 
coefficients of variance.  To each tube, 100 μl of standard or 200 μl of serum was added 
with the appropriate amount of PBS-0.1% gel to attain a total volume of 500 μl.  To all 
but TC and NSB tubes, 100 μl of primary antibody (1:210,000) and 100 μl of 125I-pLH 
(approximately 18,000 cpm/100 μl) were added.  The solution was allowed to incubate 
for 48 hours at 4°C.  The evening prior to addition, secondary antibody was prepared as 
previously described.  Following the 48 hour incubation, 100 μl of resuspended 
secondary antibody was added to all tubes except the TC tubes.  Tubes were mixed and 
allowed to incubate an additional 24 hours.  The reaction was stopped by adding 1 ml of 
cold PBS buffer to all tubes except the TC tubes.  Samples were then centrifuged at 2280 
x g for 45 minutes at 4°C.  Following centrifugation, the supernatant was poured off and 
tubes were counted for radioactivity.  Data were then analyzed using FOURFIT (Boyer  
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and Grotjan, University of South Dakota School of Medicine, Vermillion, SD), a four 
parameter logistic curve fitting program, to determine LH levels. 
 
FSH.   Iodination grade porcine FSH (AFP10640B, A.F. Parlow) was 
radioactively labeled with Na-125I using a Chloramine-T/sodium metabisulfate reaction.  
Chloramine-T oxidizes 125I from an anionic to a cationic form (Parker, 1981).  The 
cationic form of 125I is then able to react with the aromatic ring of tyrosine residues in 
porcine FSH.  Sodium metabisulfate then stops the reaction.  Briefly, 0.152 nmol of Na-
125I was added to 2.5 μg porcine FSH in 25 μl NaPO4 buffer (pH 7.4).  To this, 14.82 μg 
of Chloramine-T was added.  The reaction was allowed to proceed with intermittent, 
gentle mixing for 1 minute, at which time 34.8 μg of sodium metabisulfate was added to 
stop the reaction.  Next, 50 μl of Stop/Transfer solution was added and the mixture was 
loaded onto a Sephadex G-25 column (0.7 x 15 cm column packed with Sephadex G-25, 
equilibrated with 2 ml of 2% BSA and flushed with 20 ml of 0.05 sodium phosphate 
buffer, pH 7.4).  Fractions of 0.5 ml were collected into 13 x 100 mm glass test tubes 
containing 1.6 ml of PBS-0.1% gel.  Fractions were assessed by counting 10 μl of each 
for radioactivity using an APEX Automatic Gamma Counter (ICN Micromedic Systems).  
The first three fractions with significant counts were used to set a binding check 
(typically fractions 4-6).  The amount of each fraction needed to achieve 18,000 cpm/50 
μl was determined.  Next, calculations were performed to make primary and secondary 
antibody solutions.  The primary antibody was rabbit anti-porcine FSH (A.F. Parlow) and 
stored at a 1:40 dilution.  A working dilution of 1:300,000 was utilized for the assays.  
The secondary antibody was dARGG (Fitzgerald Industries) with a working solution of 
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15% dARGG, 0.5% normal rabbit serum (Pel-Freez Biologicals) and 84.5% PBS-0.1% 
gel.  For each fraction, tubes to determine total counts (TC), non-specific binding (NSB) 
and specific binding (Bø) were labeled and prepared (Table 3.4).  Each of the TC tubes 
contained only 50 μl 125I-pFSH at approximately 18,000 cpm/50 μl of their respective 
fraction.  The NSB tubes contained 600 μl of PBS-0.1% gel and 50 μl 125I-pFSH.  The 
Bø tubes contained 500 μl of PBS-0.1% gel, 50 μl 125I-pFSH, and 100 μl primary 
antibody.  Tubes were allowed to incubate at room temperature overnight (approximately 
14 hours).  The secondary antibody was prepared and allowed to precipitate overnight at 
room temperature.  The following morning, the secondary antibody was centrifuged at 
1500 x g for 30 minutes.  The supernatant was poured off and the pellet resuspended in 
the original volume of PBS-0.1% gel.  To each of the NSB and Bø tubes, 100 μl of 
resuspended secondary antibody was added and the mixture was allowed to incubate 1 
hour at room temperature.  Following incubation, 2 ml of ice cold PBS buffer (pH 7.4) 
was added to the NSB and Bø tubes.  The tubes were then centrifuged at 2280 x g for 30 
minutes at 4°C.  Following centrifugation, the supernatant was poured off and the tubes 
were counted for radioactivity.  Binding activity was determined by the equation:  
((Bø -NSB)/(TC))*100 = % binding 
 S e r u m  l e v e l s  o f  FS H  w e r e  m e a s u r e d  u s i n g  a  d o u b l e  a n t i b o d y 
immunoprecipitation method adapted from Niswender et al. (1970).  Levels of FSH were 
determined using an antiserum directed against porcine FSH (Lot# AFP2062096, A.F. 
Parlow), highly purified, iodinated porcine FSH as labeled hormone, and a standard 
prepared from AFP10640B (A.F. Parlow).  The assay for porcine FSH was validated as 
follows.  Serial dilutions of two independent porcine serum samples were assayed at  
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TABLE 3.4.  TUBE COMPONENTS FOR PORCINE FSH RADIOIMMUNOASSAY 
 
Tube 
PBS-0.01M 
EDTA, 1% 
BSA buffer 
125I Primary antibody 
Standard 
or 
Sample 
Secondary 
antibody 
TC --- 50 μl --- --- --- 
NSB 600 μl 50 μl --- --- 100 μl 
Bø 500 μl 50 μl 100 μl --- 100 μl 
Standard 300 μl 50 μl 100 μl 200 μl 100 μl 
Unknown 300 μl 50 μl 100 μl 200 μl 100 μl 
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volumes ranging from 12.5 to 200 μl.  Assay determinations of these dilutions from each 
of the two independent samples were highly correlated (r = 0.9985).  Parallelism was 
determined using the Allfit program (DeLean et al., 1978).  Slopes of plasma dilutions 
and the standard curve were not significantly different (P > 0.435).     
Assays were performed using the fraction with the highest binding from the 
binding check.  Prior to each assay, a protocol sheet was prepared that identified the tube 
number pertaining to each sample.  The TC, NSB and Bø were prepared as previously 
described.  The standard curve consisted of a porcine FSH standard at concentrations of 
50, 100, 200, 400, 800, 1600, and 3200 ng/ml.  The assay also contained controls of low 
and high FSH serum, as well as pooled serum used to determine intraassay coefficients of 
variance.  To each tube, 200 μl of standard or serum was added with 300 μl of PBS-
0.01M EDTA, 1% BSA (pH 7.5) to attain a total volume of 500 μl.  To all but TC and 
NSB tubes, 100 μl of primary antibody (1:300,000) and 50 μl of 125I-pFSH 
(approximately 18,000 cpm/50 μl) were added.  The solution was allowed to incubate for 
48 hours at 4°C.  The evening prior to addition, secondary antibody was prepared as 
previously described.  Following the 48 hour incubation, 100 μl of resuspended 
secondary antibody was added to all tubes except the TC tubes.  Tubes were mixed and 
allowed to incubate an additional 24 hours.  The reaction was stopped by adding 2 ml of 
cold PBS buffer to all tubes except the TC tubes.  Samples were then centrifuged at 2280 
x g for 30 minutes at 4°C.  Following centrifugation, the supernatant was poured off and 
tubes were counted for radioactivity.  Data were then analyzed using FOURFIT (Boyer 
and Grotjan, University of South Dakota School of Medicine, Vermillion, SD), a four 
parameter logistic curve fitting program, to determine FSH levels. 
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RNA Extraction    
Tissue was removed from the RNAlater solution and RNA extracted using the 
RNeasy Midi Kit (Qiagen, Inc., Valencia, CA).  Briefly, the anterior pituitary gland from 
each animal was homogenized in a 50-ml conical tube containing 2 ml of Buffer RLT (10 
μl β-mercaptoethanol per ml of Buffer RLT) using the Tissue Tearor homogenizer 
(BioSpec Products, Inc., Bartlesville, OK).  Buffer RLT inactivates RNases to ensure the 
isolation of intact RNA species.   Following homogenization, the material was transferred 
to a clean 15-ml conical tube and centrifuged for 10 minutes at 4000 x g to produce an 
upper fatty layer, supernatant and pellet.  The supernatant was removed and transferred to 
a clean 15-ml conical tube, 2 ml of 70% ethanol was added and the solution was mixed 
well.  The mixture was then added to an RNeasy Midi Spin Column (Qiagen), 
centrifuged for 5 minutes and the flow-through discarded.  Next, 4 ml of Buffer RW1 
was added to the column, and it was centrifuged for 5 minutes.  An additional two washes 
with 2.5 ml of Buffer RPE and 2 and 5 minute centrifugation steps followed.  Finally, 
RNA was eluted by adding 150 μl of RNase free water to the column and centrifuging for 
5 minutes.  The resulting flow-through was transferred to a clean 1.5-ml microcentrifuge 
tube and stored at -80°C until needed.  This method of extraction effectively isolates 
RNA species greater than 200 nucleotides while removing other contaminants.   
Quality and integrity of extracted RNA was determined by Dr. Yuannan Xia 
(Genomics Core Research Facility, UNL) using an Agilent 2100 bioanalyzer (Agilent 
Technologies, Inc., Palo Alto, CA; Fig. 3.2).  All samples used in this study met 
standards of integrity as determined by electropherogram and gel-like image results.  A 
representative image for each group is displayed in Fig. 3.3.  Total RNA quantity was  
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Figure 3.2. Examples of total RNA quality as determined using an Agilent 2100 
bioanalyzer.   Total RNA integrity was analyzed for each sample.  Determination of 
quality was made by analysis of the electropherogram and gel-like image results.  Panel 
A indicates intact total RNA suitable for use in further assays.  Panel B represents 
partially degraded total RNA and should be discarded.  
A B 
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Figure 3.3.  Representative electropherogram and gel-like image of total RNA from 
pituitaries of Index (A), Meishan (B) and Control (C) line gilts using the Agilent 2100 
bioanalyzer to determine RNA quality and integrity.     
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determined using the RiboGreen RNA Quantitation Kit (Molecular Probes, Eugene, OR) 
and a Wallac Victor2 microplate reader (Perkin Elmer, Boston, MA). 
 
Reverse Transcription   
Total RNA from each sample was treated with DNase to remove any 
contaminating genomic DNA.  Four microliters of RNA, 2 μl of RQ1 RNase free DNase 
buffer (Promega, Madison, WI) and 4 U of RQ1 RNase free DNase (Promega) were 
added to a 0.2-μl PCR tube.  The mixture was incubated at 37°C for 30 minutes and 
inactivated by the addition of 1 μl of RQ1 RNase free DNase Stop Solution (Promega) 
for 10 minutes at 65°C.  Total RNA was then quantified using the RiboGreen RNA 
Quantitation Kit as per the manufacturer’s protocol (Molecular Probes).  Reverse 
transcription (RT) of mRNA was performed using the TaqMan® Reverse Transcription 
Reagents Kit (Applied Biosystems, Foster City, CA).  In a 0.2-μl PCR tube, 1X RT 
Buffer, 5.5 μM MgCl2, 500 μM dNTP mixture,  2.5 μM random hexamers, 0.4 U RNase 
inhibitor, 3.125 U MultiScribe RT, 150 ng of RNA as calculated from the RiboGreen 
quantitation, and RNase free water were added for a 20 μl total reaction volume.  A 
mastermix of the RT reagents was prepared and added to each RNA sample.  Tubes were 
mixed and incubated at 25°C for 10 minutes to maximize random hexamer binding to 
RNA.  This was followed by a 60 minute incubation at 37°C and an inactivation step of 
95°C for 5 minutes. 
 
cDNA Quantification   
Upon completion of RT, each cDNA sample was quantified using the OliGreen  
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ssDNAQuantitation Kit (Molecular Probes) as per manufacturer’s instructions.  This 
allowed dilution to an equal cDNA concentration among samples for subsequent 
quantitative real-time PCR assays.  It also verified the presence of cDNA in the sample as 
OliGreen is more sensitive for measuring single stranded DNA species at low 
concentrations than conventional absorbance methods (Molecular Probes, 2001). 
 
Quantitative Real-Time PCR   
Quantitative real-time PCR was performed using TaqMan probes (Applied 
Biosystems Custom Oligo Synthesis Service, Foster City, CA) and primer sets 
(Integrated DNA Technologies, Coralville, IA) designed and optimized for the GnRHR, 
α-, LHβ- and FSHβ-subunits, and eukaryotic 18s rRNA (18s; Applied Biosystems) genes 
(Table 3.5). 
Each reaction was carried out in a 25 μl volume containing 1X Universal PCR 
Master Mix without Amperase UNG, appropriate amounts of primers and probes (as 
determined by optimization), 1X eukaryotic 18s rRNA mix and 2.5 ng cDNA, then 
brought to volume with nuclease free water.  Reactions were amplified in 96-well optical 
grade PCR plates with optical adhesive strips (Axygen Scientific, Inc., Union City, CA) 
in the ABI Prism 7700 Sequence Detection System (Applied Biosystems).  Real-time 
PCR cycling conditions were an initial incubation at 95°C for 10 minutes followed by 50 
cycles of denaturing at 95°C for 15 seconds and annealing and elongation at 60°C for 60 
seconds.  Primer and probe sequences were designed using Primer Express Version 1.5 
software (Applied Biosystems) and the GenBank sequence for the porcine GnRHR 
(accession #L29342), α-subunit (accession #NM 214446), FSHβ-subunit (accession #NM  
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213875) and LHβ-subunit (accession #NM 214080) genes.  Primer and probe 
combinations for 18s were supplied by the manufacturer in the eukaryotic 18s rRNA Kit 
(Applied Biosystems, Foster City, CA).  Specificity of the amplicon was determined by 
sequence analysis (Genetics Core Research Facility, UNL). Target gene (GnRHR, α-, 
FSHβ- and LHβ-subunits) probes were synthesized by Applied Biosystems with the 
reporter, 6-carboxyfluorescein (6-FAMTM), attached to the 5' end and quenching minor 
groove binder (MGB) linked to the 3' end.  The eukaryotic 18s rRNA control reagent 
(Applied Biosystems) with VIC® reporter dye was used as an endogenous control gene to 
adjust for sample loading differences.  The 6-FAMTM reporter dye is distinguishable from  
VIC® as a result of their different maximum emission wavelengths.  Appropriate 
threshold values were set for each reaction, within the range of exponentially increasing 
fluorescence, at a point of significance above baseline fluorescence.  The threshold 
reflects a point during amplification where exponential amplification is occurring that 
maximizes the precision of replicates as well as the sensitivity of the assay (Fig. 3.4). 
Optimal primer and probe concentrations for GnRHR, α-, FSHβ- and LHβ-
subunits were determined.  To determine optimal forward and reverse primer 
concentrations, the probe concentration was held at 200 nM while primer combinations 
of 100, 300, 600, and 900 nM were tested.  The primer concentrations that had the 
highest ΔRn value (the reporter signal normalized to the passive reference, ROX, for a 
given reaction) were selected for each gene.  These primer concentrations were then used 
to determine optimal probe concentrations of 100, 200 or 300 nM.  Optimal probe 
concentration was determined in a similar manner to the primers.  Optimal reaction 
conditions for GnRHR were achieved with 600 nM forward and reverse primer and 200  
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Figure 3.4. Setting of threshold in real-time PCR analysis.  From  
        www.appliedbiosystems.com. 
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nM probe.  Concentrations of 100 nM forward and reverse primer and 200 nM probe 
were determined to be optimal for α-, FSHβ- and LHβ-subunits.  The 18s rRNA is 
designed to be primer limiting to facilitate duplex reactions and was used according to 
manufacturer’s recommendations (Applied Biosystems).   
The linear dynamic range of GnRHR, α-, FSHβ- and LHβ-subunits, as well as 18s 
was determined (Fig 3.5) and the relative efficiency of the genes of interest (GnRHR, α-, 
FSHβ- and LHβ-subunits) to 18s was demonstrated (Fig 3.6).  In order to make accurate 
comparisons between samples, the efficiency of the target gene must be similar to that of 
the endogenous control regardless of starting template amounts and expression levels.  To 
show this, serial dilutions of cDNA representative of each gene were run in triplicate 
using optimized primer and probe concentrations.  The average CT for each dilution was 
plotted against the log of the input cDNA amount to ensure linearity.  To determine 
relative efficiency, the difference between the CT of the genes of interest and the CT of 
18s (ΔCT) was plotted against the log starting input of cDNA.  A slope with a value of    
< 0.1 is indicative that the efficiency between the two genes would be similar at all 
dilutions (Applied Biosystems, 2001).  If the relative efficiency between the two genes is 
not equal, comparisons between the samples would not be reliable. 
 
TaqMan Data Analysis   
Following completion of the real-time PCR reaction for samples for each animal, 
the baseline and threshold to determine CT were established.  The CT represents the cycle 
number at which the fluorescence generated passes the fixed threshold and reflects a 
point where a significant number of amplicons have accumulated to produce a signal  
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Figure 3.5.  Linear dynamic range and efficiency of real-time PCR assays.  Dilutions of 
cDNA were assayed to determine the linearity and efficiency of each assay.  The average 
CT value for each dilution was plotted against the log of the input cDNA amount.  A slope 
of -3.3 represents 100% PCR efficiency and should be no less than -3.6 (90%). 
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Figure 3.5 continued. 
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Figure 3.6.  Relative efficiency of real-time PCR assays for each gene of interest 
compared to eukaryotic 18s rRNA.  Dilutions of cDNA were assayed for both the gene of 
interest and 18s rRNA.  The average ΔCT was plotted against the log input amount of 
cDNA for each dilution point.  A slope with an absolute value of < 0.1 indicates equal 
PCR efficiencies and validates use of the ΔΔCT method of analysis. 
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above that of the baseline.  Fewer cycles to reach the threshold represent a greater amount 
of gene expression whereas an increased number of cycles represent lower levels of 
expression.  The comparative CT method was used to evaluate data obtained from the 
duplex reactions (Applied Biosystems, 2001).  This method expresses data relative to a 
calibrator sample.  The ΔCT for GnRHR and α-, FSHβ- and LHβ-subunits compared to 
18s was calculated to account for the amount of template added to each reaction.  Then, 
the ΔCT for an arbitrary calibrator was subtracted from each sample ΔCT (ΔΔCT).  The 
final value is expressed as 2-ΔΔCT.  The data were also analyzed using the normalization 
procedure.  This method incorporates a reference gene that is expressed at the same level 
in the tissue regardless of treatment.  Using this analysis, the CT for each of the target 
genes is divided by the CT for 18s to correct for template starting amounts. 
 
GeneChip® Porcine Genome Array   
Total RNA was assayed for gene expression using the Affymetrix GeneChip® 
Porcine Genome Array (Affymetrix Inc., Santa Clara, CA).  The assay was performed in 
the Genomics Core Research Facility at the University of Nebraska-Lincoln.  Briefly, 
total RNA from the extraction described previously was pooled within breed x treatment 
groups (n = 5 to 6 gilts per group) and RNA was precipitated by adding 0.3 M sodium 
acetate followed by 1 volume of isopropanol.  The solution was mixed and incubated at -
20°C for one hour at which time it was centrifuged at 12,000 x g for 30 minutes at 4°C.  
Following centrifugation, the supernatant was removed and the resulting pellet was 
washed with 70% ethanol.  The ethanol was removed and the pellet was allowed to dry.  
The RNA pellet was then resuspended in 100 μl RNase free water.  To this, 350 μl of 
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Buffer RLT (Qiagen, Inc.) was added followed by 250 μl of 100% ethanol.  After mixing, 
the solution was applied to an RNeasy Mini column placed in a 2-ml collection tube and 
centrifuged at 8,000 x g for 15 seconds.  The RNeasy Mini column was then transferred 
to a new 2-ml collection tube.  To the column, 500 μl of Buffer RPE was added and it 
was centrifuged as described above.  The flow-through was discarded and an additional 
500 μl of Buffer RPE was added to the column.  This was followed by centrifugation at 
8,000 x g for 2 minutes.  The RNeasy Mini column was then placed in a fresh 1.5-ml tube 
and 35 μl of RNase free water was added to the column followed by centrifugation at 
8,000 x g for 1 minute.  The RNA was quantified using RiboGreen, as previously 
mentioned, and diluted to a concentration of 2 μg/μl and delivered to the Genomics Core 
Research Facility (UNL).  Samples were analyzed for quality and integrity using an 
Agilent 2100 bioanalyzer (Agilent Technologies, Inc.).   
The Affymetrix GeneChip® System uses arrays fabricated by direct synthesis of 
oligonucleotide probes on glass slides using photolithographic technology.  Hybridization 
to the chip is DNA:RNA.  Antisense copy RNA (cRNA), made from double stranded 
cDNA that was derived from the mRNA samples, was transcribed in vitro using T7 RNA 
polymerase in the presence of biotinylated CTP and UTP.  The hybridized probe array 
was stained with streptavidin phycoerythrin conjugate and scanned by the GeneChip® 
Scanner 3000 (Affymetrix, Inc.). The amount of light emitted at 570 nm is proportional 
to the bound target at each location on the probe array.  Samples from each breed x 
treatment group (n = 6) were hybridized on separate chips and then compared after 
analysis.  Analysis of image data was achieved using GeneChip® Operating Software 
(Version 1.2; Affymetrix, Inc.).  Each pooled sample was run in duplicate.  Normalized 
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data from the GeneChip® Operating Software package was analyzed using GeneSifter 
(VizX Labs LLC, Seattle, WA; http://www.genesifter.net).  Differential expression of 
genes was determined by averaging duplicate arrays and running a pair-wise analysis. 
Statistical significance was determined by Student’s t test and genes with differences (P < 
0.05) were included in the analysis. 
 
Statistical Evaluation   
Statistical evaluation was conducted using the Statistical Analysis System (SAS,  
2001). Values for LH and FSH were analyzed using the Proc GLM procedure.  The LH 
means were logarithmically transformed due to nonnormality, analyzed for significance, 
and back-transformed to the original scale (Bland and Altman, 1996).  Least-squares 
means for both LH and FSH were compared using least significant differences.  The 
statistical model used was as follows: Yijk = μ + Li + Tj + (LT)ij + εijk, where Y is the 
response variable (LH), μ is the overall mean of the response variable, L is the line effect 
(Control, Index, Meishan), T is the treatment effect (SB-75 or vehicle), and ε is the 
residual.  The expression levels of GnRHR and α-, FSHβ- and LHβ-subunit genes were 
analyzed using the Proc GLM procedure.  The normalized, as well as 2-ΔΔCT, amount of 
mRNA for each group was analyzed.  Least squares means for amounts of GnRHR, α-
subunit and LHβ-subunit gene expression were logarithmically transformed due to 
nonnormality, analyzed for significance, back-transformed to the original scale (Bland 
and Altman, 1996), and compared using least significant differences.  Least squares 
means for FSHβ-subunit expression levels using the 2-ΔΔCT method were square root 
transformed due to nonnormality, analyzed, back-transformed to the original scale (Bland 
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and Altman, 1996), and compared using least significant differences.  Least squares 
means for the 2-ΔΔCT method are expressed as relative expression over the arbitrary 
calibrator.  Means for normalized data are expressed as expression relative to 18s rRNA.  
The statistical model used was as follows: Yijk = μ + Li + Tj + (LT)ij + εijk, where Y is 
the response variable (normalized or 2-ΔΔCT expression), μ is the overall mean of the 
response variable, L is the line effect (Control, Index, Meishan), T is the treatment effect 
(SB-75 or vehicle), and ε is the residual. 
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CHAPTER IV 
 
Responsiveness of GnRH Receptor and Gonadotropin Subunit Genes Following 
Treatment with the GnRH Antagonist, SB-75, in Lines of Swine Divergent for 
Ovulation Rate 
Abstract 
 The interaction of GnRH with its receptor represents a crucial point for control of 
reproductive function, regulating expression of genes encoding the gonadotropin subunits 
and GnRH receptor (GnRHR) itself.  In addition to its physiological relevance, the 
porcine GnRHR gene is a positional candidate for genes that influence reproductive 
efficiency because it is located in a similar chromosomal region to a quantitative trait 
locus (QTL) for ovulation rate (OR).  Evaluation of gonadotropic gene expression in lines 
of swine divergent for ovulation rate may provide insight into the phenomena of 
increased litter size.  Chinese Meishan (OR = 14.5), a white crossbred line selected for 
several generations based on an index of OR and embryonic survival (Index; OR = 17.8), 
and a control line (Control; OR = 13.2) were evaluated in this study.  Following three 
(Index and Control) or six (Meishan) successive estrous cycles, gilts were ovariectomized 
to remove endogenous steroid hormones.  After a 21 d recovery period, gilts from each 
line were treated with either a specific GnRH antagonist (SB-75; 10 μg/kg bw) or 0.9% 
saline at 60, 36 and 12 h prior to sacrifice.  Blood samples were collected prior to the first 
treatment and at sacrifice before anterior pituitary collection.  Serum LH and FSH levels 
were determined by RIA, and RNA was extracted from anterior pituitary tissue.  In all 
breeds, LH was reduced to basal levels by SB-75 treatment, confirming the efficacy of 
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SB-75.  In contrast, levels of FSH decreased only in Control gilts following treatment 
with SB-75.  Levels of GnRHR and gonadotropin subunit gene expression were 
measured by quantitative real-time PCR.  Basal expression of the GnRHR gene was 
higher in Meishan compared to Control pituitaries, but Index GnRHR mRNA levels were 
similar to both lines.  Levels of pituitary GnRHR gene expression were reduced in 
Control and Index, but not Meishan females following treatment.  Initial amounts of 
glycoprotein α-subunit mRNA were highest in Control and Index compared to Meishan 
anterior pituitary tissue.  Further, α-subunit expression decreased following treatment in 
pituitaries from the Control and Index lines only.   Prior to SB-75 treatment, pituitary 
FSHβ-subunit mRNA levels were higher in Control and Index compared to Meishan gilts.  
After treatment, FSHβ-subunit mRNA levels decreased in Control and Index but not in 
Meishan gilts.  Expression of the LHβ-subunit gene was highest in Control, intermediate 
in Index and lowest in Meishan pituitaries; however, amounts of LHβ-subunit mRNA 
decreased in Control and Index following treatment and remained unchanged in Meishan.  
Thus, GnRHR and gonadotropin subunit gene expression patterns in lines of swine 
divergent for OR suggest differential mechanisms for GnRH regulation of gonadotrope 
function. 
 
Introduction 
 Prolificacy of females is an important measure of productivity in the swine 
industry, representing a trait of dramatic economic importance.  Two major components 
of litter size are uterine capacity and ovulation rate, a trait that differs significantly 
between strains of swine.  While uterine capacity is a key component to litter size, it is 
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not easily quantified thus making selection for this trait difficult.  Ovulation rate, 
however, can be improved in many ways including nutritional flushing and genetic 
selection.  However, there is very little known about the mechanisms behind increased 
ovulation rate in swine. 
Two principal components of ovulation rate, follicle recruitment and ovulation, 
are stimulated by the gonadotropins, follicle-stimulating hormone (FSH) and luteinizing 
hormone (LH), respectively.  The pulsatile release of GnRH from the hypothalamus and 
its subsequent binding to specific high-affinity receptors on gonadotrope cells within the 
anterior pituitary gland not only stimulates, but is also obligatory to the synthesis and 
secretion of FSH and LH (Clayton and Catt, 1981; Clarke et al., 1983).  The 
gonadotropins are heterodimeric glycoproteins, each sharing a common α-subunit; 
however, it is the individual β-subunits that give FSH and LH biological specificity.  The 
interaction of GnRH with the GnRHR stimulates the expression of at least four genes 
including the α-subunit, LHβ- and FSHβ-subunits, and the GnRHR itself.  In addition to 
the amount of GnRH available, gonadotropin secretion is dependent on the number of 
GnRHRs available, establishing their importance in normal reproductive function (Wise 
et al., 1984).  Unique to the pig, the GnRHR gene lies in a similar chromosomal region as 
a QTL for OR (Rohrer, 1999).  Therefore, the GnRHR gene represents both a 
physiological and positional candidate for genes determining ovulation rate in swine.   
Pulse amplitude and pattern of GnRH stimulation differentially regulate 
expression of the gonadotropin subunit genes (α-, FSHβ and LHβ-subunits; Haisenleder 
et al., 1991).  Also, gonadotropin subunit mRNA is differentially regulated following 
ovariectomy (Burger et al., 2001).  The FSHβ-subunit gene is regulated by GnRH to a 
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lesser extent than the α- and LHβ-subunits, and is positively regulated by activin (Weiss 
et al., 1992).  However, estradiol-17β (Guthrie and Bolt, 1985) and inhibin (Braden et al., 
1990) have negative actions on expression of the FSHβ-subunit gene.  Estradiol-17β also 
functions to prime GnRHR numbers (Gregg et al., 1990) and preferentially stimulates 
transcription of the LHβ-subunit gene in anterior pituitary cell cultures (Shupnik et al., 
1989).  Differential regulation of the gonadotropin subunits creates the potential for 
differential secretion of the respective gonadotropins during the estrous cycle. 
 Follicular development is dependent on the actions of FSH and LH at the level of 
the ovary (Lucy et al., 2001).  The production of FSH and LH in response to GnRH 
stimulation is correlated with the number of GnRHRs present on the gonadotrope cell 
surface within the anterior pituitary gland (Wise et al., 1984).  Sensitivity to GnRH and 
other hormones, or number of GnRHRs present on the anterior pituitary gland may 
stimulate higher levels of gonadotropin production and thus, increase ovulation rate.  A 
study by Knox et al. (2003) indicated that concentrations of both FSH and LH were 
elevated in lines of swine with increased OR (17 to 26 CL) when compared to control 
lines (12 to 16 CL).          
 The genomic sequence for the porcine GnRHR gene was reported by Jiang and 
associates (2001).  Sequence analysis revealed several polymorphisms within the coding 
sequence for the GnRHR gene between Chinese Meishan and white crossbred pigs, 
resulting in at least three amino acid substitutions.  The Chinese Meishan breed of swine 
is one of the most prolific breeds, producing four to five more piglets per litter than 
occidental lines, due, in part, to increased OR (White et al., 1993; Christenson et al., 
1993).  Consistent with this model, scientists at the University of Nebraska – Lincoln 
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(UNL) have developed a line of pigs that were selected for greater than 14 generations 
based on an index of OR and embryonic survival at 50 d of gestation.  This line of white 
crossbred pigs ovulates seven more eggs each cycle (Generation 10; Johnson et al., 1999) 
and produces 2.53 more live born piglets per litter than control animals (Control; 
Generation 19; Petry and Johnson, 2004).  Using these genetic models, the objective of 
this study was to examine expression patterns of the GnRHR and gonadotropin subunit 
genes in lines of swine divergent for OR.   
 
Materials and Methods 
Animals.  All animal procedures used in this study were approved by the UNL 
Institutional Animal Care and Use Committee.  White crossbred Index and Control line 
gilts (Generation 23) were transported to the UNL Animal Science Building from the 
University of Nebraska Agricultural Research and Development Center (ARDC) Swine 
Unit.  Gilts of the Meishan breed were transported to the Animal Science Building from 
the United States Department of Agriculture, Roman L. Hruska U.S. Meat Animal 
Research Center in Clay Center, Nebraska.  Gilts were housed in pens with a minimum of 
8 square feet of floor space, 4 pounds of feed per day and water available ad libitum.  
Gilts of the Index and Control lines were detected for estrus beginning at 155 days of age 
whereas estrous detection began at 95 days of age for Meishan females.   
 
Treatments.  Upon completion of the third (Index and Control) or sixth 
(Meishan) estrus, ten gilts from the Index and Control lines and 12 Meishan gilts were 
ovariectomized during the luteal phase (Day 5 to 15 of the estrous cycle).  A preliminary 
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study in our laboratory and previous reports (Christenson et al., 1993; Hunter et al., 1993) 
indicated that Meishan gilts do not exhibit increased ovulation rates following three 
estrous cycles when compared to gilts occidental breeds.  Thus, Meishan females were 
allowed an additional three estrous cycles to achieve OR at a level above that of control 
gilts.  Twenty-one days after ovariectomy, gilts from each line were randomly assigned to 
treatment groups and received an injection of either the specific GnRH antagonist, SB-75 
(10 μg biologically active compound per kg of body weight; UNL Protein Core Facility), 
or vehicle (0.9% saline) at 60, 36 and 12 hours prior to sacrifice (Fig. 3.1).   
  
Serum and Tissue Collection.  Blood samples were collected via jugular 
venopuncture prior to ovariectomy and the first SB-75 injection.  Gilts from the Index, 
Control and Meishan lines were transported to the UNL abattoir the morning of sacrifice.  
Animals were rendered unconscious by electrical stunning followed by exsanguination.  
At this time, a blood sample and the head were collected.  The pituitary gland was 
excised and transferred to a sterile Petri dish using RNase free utensils.  The anterior and 
posterior pituitaries were separated and the anterior pituitary was divided into quarters.  
One quarter was placed in a sterile 2-ml cryovial and snap frozen in liquid nitrogen.  The 
remaining three quarters of the pituitary (approximately 65 mg of tissue per quarter) were 
placed in RNAlater (Ambion, Inc., Austin, TX) and kept on ice for later RNA extraction.   
 
Radioimmunoassay.  Concentrations of serum LH were determined using an 
RIA validated in our laboratory.  Iodination grade porcine LH (AFP11043B, A.F. Parlow, 
National Hormone & Peptide Program, Harbor-UCLA Medical Center, Torrance, 
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California) was iodinated using a “controlled” chloramine-T method (Proudman and 
Wentworth, 1978) and then used to measure LH concentrations.  A standard curve 
ranging from 0.03 – 5.0 ng/ml was used (prepared from AFP11043B).  The porcine LH 
antibody (AFP15103194Rb, A.F. Parlow) was used at a working dilution of 1:210,000.  
Standards and samples were added to numbered glass tubes.  Next, the porcine LH 
antibody and iodinated LH were added and this mixture was allowed to incubate for 48 
hours at 4°C.  Second antibody [89% phosphate buffered saline-0.1% gel (PBS-gel), 
10.5% donkey anti-rabbit gammaglobulin (dARGG), 0.5% normal rabbit serum (NRS)] 
was then added, followed by an incubation of 24 hours at 4°C.  One ml of PBS buffer 
was added followed by centrifugation at 3200 x g for 45 minutes.  Supernatant was 
removed and pellets counted for radioactivity.   
 Serum FSH concentrations were determined using an RIA validated in our   
laboratory.  Iodination grade porcine FSH (AFP10640B, A.F. Parlow) was used to 
determine FSH concentrations.  A standard curve ranging from 200 – 3200 ng/ml was 
used (prepared from AFP10640B).  The porcine FSH antibody (AFP2062096, A.F. 
Parlow) was used at a working dilution of 1:300,000.  Standards and samples were added 
to numbered glass tubes.  Next, the porcine FSH antibody and iodinated FSH were added 
and this mixture was allowed to incubate for 48 hours at 4°C.  Second antibody (84.5% 
PBS-0.1% gel, 15% dARGG, 0.5% NRS) was then added, followed by an incubation of 
24 hours at 4°C.  One ml of PBS buffer was added followed by centrifugation at 3200 x g 
for 30 minutes.  Supernatant was removed and pellets counted for radioactivity. 
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RNA Extraction and Reverse Transcription.  Tissue was removed from the 
RNAlater solution and RNA extracted using the RNeasy Midi Kit as per manufacturer’s 
instructions (Qiagen, Inc., Valencia, CA).  Quality and integrity of extracted RNA was 
determined at the Genomics Core Research Facility (UNL) using an Agilent 2100 
bioanalyzer (Agilent Technologies, Inc., Palo Alto, CA).  Total RNA from each animal 
was treated with DNase to remove any contaminating genomic DNA.  Four μl of RNA, 2 
μl of RQ1 RNase-free DNase buffer (Promega, Madison, WI) and 4 U of RQ1 RNase-
free DNase (Promega) were added to a 0.2-ml PCR tube.  The mixture was incubated at 
37°C for 30 minutes and inactivated by the addition of 1 μl of RQ1 RNase-free DNase 
Stop Solution (Promega) for 10 minutes at 65°C.  Total RNA quantity was determined 
using the RiboGreen RNA Quantitation Kit (Molecular Probes, Eugene, OR) and a 
Wallac Victor2 microplate reader (Perkin Elmer, Boston, MA).  Reverse transcription 
(RT) of mRNA was performed using the TaqMan® Reverse Transcription Reagents Kit 
(Applied Biosystems, Foster City, CA).  In a 0.2-μl PCR tube, 1X RT Buffer, 5.5 μM 
MgCl2, 500 μM dNTP mixture, 2.5 μM random hexamers, 0.4 U RNase inhibitor, 3.125 
U MultiScribe RT, 150 ng of RNA (calculated from the RiboGreen quantitation), and 
RNase-free water were added for a 20 μl total reaction volume.  Tubes were mixed and 
incubated at 25°C for 10 minutes, followed by 60 minute incubation at 37°C and an 
inactivation step of 95°C for 5 minutes.  The cDNA from each sample was quantified 
using the OliGreen ssDNA Quantitation Kit (Molecular Probes) as per manufacturer’s 
instructions.       
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Quantitative Real-time PCR.  Primers (Table 3.4) were designed for the 
GnRHR, α-, FSHβ- and LHβ-subunit genes according to GenBank sequences using 
Primer Express (Version 1.5; Applied Biosystems).  Real-time PCR was carried out using 
an ABI Prism 7700 (Applied Biosystems) using gene-specific probes (Table 3.4) for the 
detection of PCR products.  The final 25 μl reaction contained 1X Universal PCR Master 
Mix without Amperase UNG, 200 nM (α-, FSHβ- and LHβ-subunits) or 600 nM 
(GnRHR) forward and reverse primer, 200 nM probe, 1X eukaryotic 18s rRNA mix and 
2.5 ng cDNA, then brought to final volume with nuclease free water.  Reactions were 
amplified in 96-well optical grade PCR plates with optical adhesive strips (Axygen 
Scientific, Inc., Union City, CA).  Real-time PCR cycling conditions were an initial 95°C 
incubation for 10 minutes followed by 50 cycles of denaturing at 95°C for 15 seconds 
and annealing and elongation at 60°C for 60 seconds.  Ribosomal 18s RNA was used as 
an endogenous control for each sample, and the Ct value of each sample was normalized 
to that of 18s rRNA. 
 
Statistical Analysis.   Statistical evaluation was conducted using the General  
Linear Models procedure of the Statistical Analysis System (SAS, 2001).  The LH means 
were logarithmically transformed due to nonnormality, analyzed for significance and 
back-transformed to the original scale (Bland and Altman, 1996) prior to analysis.  Least-
squares means for LH and FSH were compared using least significant differences.  Least 
squares means for expression levels of GnRHR and α-, FSHβ- and LHβ-subunit genes 
were logarithmically transformed due to nonnormality, analyzed for significance, back-
transformed to the original scale (Bland and Altman, 1996), and compared using least 
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significant differences.  Means for normalized data are expressed as a ratio of the gene of 
interest relative to 18s rRNA. 
 
Results 
Radioimmunoassay.  Serum collected before and after ovariectomy and 
following treatment at sacrifice was assayed for LH and FSH concentration. Levels of LH 
in gilts prior to ovariectomy were similar between Control (1.25 ng/ml), Meishan (1.21 
ng/ml), and Index (1.05 ng/ml) lines (P > 0.05).  Serum LH levels increased significantly 
following ovariectomy (P < 0.05) but did not differ between lines after ovariectomy (Fig. 
4.1).  Treatment with SB-75 caused a significant reduction in LH compared to gilts given 
vehicle in all lines (P < 0.001; Fig. 4.2).  The decrease in LH following treatment 
indicated the ability of SB-75 to antagonize GnRH action at the GnRHR.   
Levels of serum FSH were also similar between Control (432.89 ng/ml), Index 
(408.56 ng/ml) and Meishan (382.85 ng/ml) gilts prior to ovariectomy, significantly 
increasing following removal of ovaries (Figure 4.3).  Post-ovariectomy levels of FSH 
were higher in Control gilts compared to Index or Meishan females (P <0.05).  Serum 
FSH levels decreased in Control gilts (P < 0.01) and had a tendency to decline in Index 
gilts following treatment with SB-75 (P < 0.10).  Conversely to LH results, Meishan FSH 
levels remained elevated following SB-75 treatment (Fig. 4.4).  
 
Gene Expression.  Anterior pituitary levels of GnRHR mRNA were highest in 
Meishan, intermediate in Index, and lowest in Control line gilts when normalized to 18s 
rRNA expression (Fig. 4.5).  Treatment with SB-75 caused a reduction of GnRHR gene 
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expression in the Index and Control lines (P < 0.05), but there was only a trend for a 
decrease in GnRHR mRNA levels in Meishan gilts (P < 0.10).  Analysis using the ΔΔCT 
method was in agreement with normalization, however, Meishan and Index GnRHR  
expression levels were similar (P > 0.05; Fig. 4.6). 
 In pituitaries from Meishan gilts, levels of α-subunit mRNA were lower than 
those of Control and Index gilts.  Following treatment with SB-75, a significant reduction 
was observed in pituitary α-subunit gene expression of Control and Index lines (P < 
0.0001).  Similar to the GnRHR gene, levels of α-subunit mRNA in Meishan anterior 
pituitaries were unchanged (Fig 4.7).  Results using the ΔΔCT method confirmed the 
normalized data (Fig 4.8).  
 As was observed with the α-subunit, levels of pituitary FSHβ-subunit gene 
expression were lower in the Meishan compared to Control and Index lines.  There was a 
decrease in values for FSHβ-subunit mRNA in anterior pituitaries of both Control and 
Index gilts receiving treatment with SB-75 (P < 0.0001); however there was no change in 
FSHβ-subunit expression levels in Meishan gilts (Fig. 4.9).  Pituitary expression of the 
FSHβ-subunit in the Index line was intermediate compared to Control and Meishan gilts 
(P < 0.05) using the ΔΔCT method to analyze real-time PCR data.  Similar to 
normalization to 18s rRNA, FSHβ-subunit gene expression in pituitaries from the Index 
and Control lines decreased with SB-75 treatment, but FSHβ-subunit mRNA levels in the 
Meishan breed were unchanged (Fig. 4.10). 
 Anterior pituitary levels of LHβ-subunit mRNA were lower in Meishan than 
Control gilts (P < 0.05), with Index gilts being intermediate, prior to treatment.  A 
decrease in LHβ mRNA levels was observed in pituitaries from Control and Index gilts 
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treated with SB-75 (P < 0.0001).  There was no significant decline in LHβ-subunit gene 
expression in pituitaries of Meishan females (Fig. 4.11).  Pituitary levels of LHβ-subunit 
mRNA were similar to the normalized data in all untreated groups using the ΔΔCT 
method (P > 0.05).  Similar to normalization, levels of LHβ-subunit mRNA were 
decreased with SB-75 treatment in pituitaries from all lines but Meishan (Fig. 4.12). 
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Figure 4.1.  Changes in serum LH levels in Control, Index and Meishan gilts before (Pre-
OVX) and after (Post-OVX) ovariectomy and following treatment with vehicle or the 
GnRH antagonist, SB-75.  Gilts were ovariectomized and treated with 0.9% saline or a 
specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior to slaughter.  Each bar 
represents the least-squares mean ± SEM of 5-6 gilts.  Bars with asterisks are different 
than Pre-OVX and SB-75 treated groups (P < 0.05). 
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Figure 4.2.  Changes in serum LH levels in Control, Index and Meishan gilts following 
treatment with vehicle or the GnRH antagonist, SB-75.  Gilts were ovariectomized and 
treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior 
to slaughter.  Each bar represents the least-squares mean ± SEM.  Bars with different 
letters are different (P < 0.001). 
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Figure 4.3. Changes in serum FSH levels in Control, Index, and Meishan gilts before 
(Pre-OVX) and after (Post-OVX) ovariectomy and following treatment with vehicle or 
the GnRH antagonist, SB-75.  Gilts were ovariectomized and treated with 0.9% saline or 
a specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior to slaughter.  Each bar 
represents the least-squares mean ± SEM of 5-6 gilts.  Bars with asterisks are different 
than Pre-OVX (P < 0.05). 
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Figure 4.4.  Changes in serum FSH levels in Control, Index and Meishan gilts following 
treatment with vehicle or the GnRH antagonist, SB-75.  Gilts were ovariectomized and 
treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 36, and 12 h prior 
to slaughter.  Each bar represents the least-squares mean ± SEM.  Bars with different 
letters are different (P < 0.01). 
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Figure 4.5. Normalized expression of the GnRHR gene in pituitaries of Control, Index 
and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75.  Gilts were 
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 
36, and 12 h prior to slaughter.  The anterior pituitary gland was collected and RNA 
extracted.  Using specific primers and probes, real-time PCR was performed to determine 
levels of GnRHR mRNA.  Normalized values are expressed as the CT measured for 
GnRHR divided by the CT measured for 18s rRNA (± SEM).  Bars with different letters 
are different (P < 0.05). 
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Figure 4.6. Relative expression of the GnRHR gene in Control, Index and Meishan gilts 
treated with vehicle or the GnRH antagonist, SB-75.  Gilts were ovariectomized and 
treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 36, and 12 h prior 
to slaughter.  The anterior pituitary gland was collected and RNA extracted.  Using 
specific primers and probes, real-time PCR was performed to determine levels of GnRHR 
mRNA.  Analysis was carried out using the ΔΔCT method.  Bars with different letters are 
different (P < 0.05). 
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Figure 4.7.  Normalized expression of the α-subunit gene in pituitaries of Control, Index 
and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75.  Gilts were 
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 
36, and 12 h prior to slaughter.  The anterior pituitary gland was collected and RNA 
extracted.  Using specific primers and probes, real-time PCR was performed to determine 
levels of α-subunit mRNA.  Normalized values are expressed as the CT measured for the 
α-subunit gene divided by the CT measured for 18s rRNA (± SEM).  Bars with different 
letters are different (P < 0.05). 
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Figure 4.8.  Relative expression of the α-subunit gene in Control, Index and Meishan gilts 
treated with vehicle or the GnRH antagonist, SB-75.  Gilts were ovariectomized and 
treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 36, and 12 h prior 
to slaughter.  The anterior pituitary gland was collected and RNA extracted.  Using 
specific primers and probes, real-time PCR was performed to determine levels of α-
subunit mRNA.  Analysis was carried out using the ΔΔCT method.  Bars with different 
letters are different (P < 0.05). 
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Figure 4.9.  Normalized expression of the FSHβ-subunit gene in pituitaries of Control, 
Index and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75.  Gilts were 
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 
36, and 12 h prior to slaughter.  The anterior pituitary gland was collected and RNA 
extracted.  Using specific primers and probes, real-time PCR was performed to determine 
levels of FSHβ-subunit mRNA.  Normalized values are expressed as the CT measured for 
the FSHβ-subunit gene divided by the CT measured for 18s rRNA (± SEM).  Bars with 
different letters are different (P < 0.05). 
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Figure 4.10.  Relative expression of the FSHβ-subunit gene in Control, Index and 
Meishan gilts treated with vehicle or the GnRH antagonist, SB-75.  Gilts were 
ovariectomized and treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 
36, and 12 h prior to slaughter.  The anterior pituitary gland was collected and RNA 
extracted.  Using specific primers and probes, real-time PCR was performed to determine 
levels of FSHβ-subunit mRNA.  Analysis was carried out using the ΔΔCT method.  Bars 
with different letters are different (P < 0.05). 
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Figure 4.11. Normalized expression of the LHβ-subunit gene in pituitaries of Control, 
Index and Meishan gilts treated with vehicle or the GnRH antagonist, SB-75.  Gilts were 
ovariectomized and treated with 0.9% saline or a specific GnRH antagonist, SB-75, at 60, 
36, and 12 h prior to slaughter.  The anterior pituitary gland was collected and RNA 
extracted.  Using specific primers and probes, real-time PCR was performed to determine 
levels of LHβ-subunit mRNA.  Normalized values are expressed as the CT measured for 
the LHβ-subunit gene divided by the CT measured for 18s rRNA (± SEM).  Bars with 
different letters are different (P < 0.05). 
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Figure 4.12. Relative expression of the LHβ-subunit gene in Control, Index and Meishan 
gilts treated with vehicle or the GnRH antagonist, SB-75.  Gilts were ovariectomized and 
treated with a specific GnRH antagonist, SB-75, or 0.9% saline at 60, 36, and 12 h prior 
to slaughter.  The anterior pituitary gland was collected and RNA extracted.  Using 
specific primers and probes, real-time PCR was performed to determine levels of LHβ-
subunit mRNA.  Analysis was carried out using the ΔΔCT method.  Bars with different 
letters are different (P < 0.05). 
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Discussion 
 
Binding of GnRH to its receptor leads to the synthesis and release of the 
gonadotropins, implicating the physiological role of the GnRHR in reproductive function.  
Further, the GnRHR gene is located in a similar region of porcine chromosome 8 as a 
QTL for OR (Rohrer 1999).  Therefore, the GnRHR gene represents both a physiological 
and positional candidate for genes influencing OR.  In addition, the gonadotropins 
contribute to key components of OR, follicle recruitment (FSH) and ovulation (LH).    
Recognizing the physiological importance of the GnRHR and gonadotropins in 
determination of OR, we explored the response of genes encoding the GnRHR and 
gonadotropin subunits to treatment with the GnRH antagonist, SB-75, in ovariectomized 
females from lines of swine divergent for OR. 
In the current study, there was no difference in levels of serum LH or FSH 
between groups before or after ovariectomy.  Accordingly, Tilton and associates (1994) 
also reported no difference in the amount of serum FSH or LH between Meishan and 
white crossbred gilts following ovariectomy.  Others have reported similar LH or FSH 
levels between white crossbred and Meishan sows prior to ovariectomy; however LH 
levels were elevated in white crossbred over Meishan sows following ovariectomy (Wise 
et al., 2001).  In our experiment, the effectiveness of the GnRH antagonist, SB-75, was 
established based on a decline in LH levels of ovariectomized gilts receiving treatment.  
In contrast, whereas levels of serum FSH increased following ovariectomy in all lines, a 
significant response to treatment with SB-75 was only observed in Control gilts.  In a 
previous study, a decrease in serum LH following treatment with SB-75, with only a 
modest effect on FSH concentration, in Meishan and white crossbred sows was also 
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observed (Wise et al., 2001).  Others have also reported that treatment with SB-75 does 
not affect FSH concentrations as strongly as LH levels, possibly due to differential 
regulation of the gonadotropin β-subunits or the half-life of FSH (Reissmann et al., 
2000).  Gonadotropin concentrations following treatment with SB-75 suggest that GnRH 
stimulation of gonadotropes regulates production and secretion of FSH and LH in a 
differential manner. 
Tilton and colleagues (1994) reported that ovariectomized Large White gilts had 
higher FSH and LH levels than Meishan gilts following GnRH treatment.  Levels of FSH 
and LH returned to baseline in 90 and 60 minutes, respectively, in Meishan females but 
remained elevated in Large White females for at least 4 hours.  In addition, when these 
gilts were treated with porcine follicular fluid, a more substantial effect on FSH was 
observed in the Large White than Meishan gilts.  This suggests that Large White females 
may have greater sensitivity to ovarian negative feedback than Meishan females (Hunter, 
1993).  Large White females may harbor a larger releasable pool of gonadotropins, 
metabolize GnRH less effectively, or have greater pituitary sensitivity to GnRH than 
Meishan females, which may explain the differential gonadotropin response to GnRH 
(Tilton et al., 1994).  However, another study indicated that Meishan sows demonstrated 
a longer duration of declined FSH concentrations following treatment with SB-75 
compared to white crossbred sows (Wise et al., 2001).  There may also be differences in 
the clearance rate or receptor binding properties of gonadotropins between Meishan and 
white crossbred females (Wise et al., 2001).     
In the current study, expression levels of GnRHR and the gonadotropin subunits 
declined following treatment with SB-75 in Index and Control, but not Meishan gilts.  
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This indicates that GnRH exerts differential effects on regulation of gonadotropin subunit 
gene expression among lines of swine.  Regulation of the gonadotropin subunits most 
likely occurs at the level of the anterior pituitary (GnRHR) rather than the hypothalamus 
(GnRH).  Within the gonadotrope, GnRH possesses the ability to stimulate differential 
expression of the GnRHR and gonadotropin subunit genes (Weiss et al., 1992a).  
Frequency-dependent regulation of FSHβ- and LHβ-subunit promoter expression by 
GnRH was observed in LβT2 cells and male rat primary pituitary cultures with FSHβ- 
and LHβ-subunits stimulated at low and high GnRH pulse frequencies, respectively 
(Bedecarrats and Kaiser, 2003; Kaiser et al., 1997).  Patterns of the gonadotropins in 
serum followed that of their respective subunits; however, there was a greater LH:FSH 
ratio with more frequent GnRH pulses.  Interestingly, levels of GnRHR mRNA were 
more closely correlated with those of the LHβ-subunits than the FSHβ-subunit (Kaiser et 
al., 1997).  Similar to Kaiser and associates (1997), we determined that anterior pituitary 
levels of GnRHR and LHβ-subunit mRNA mimicked each other in all lines following 
SB-75 treatment.  Levels of the GnRHR and gonadotropin subunit genes were only 
measured at one time-point and GnRH levels were not determined in our study, thus a 
relationship between GnRH and expression levels of the genes studied could not be 
determined.  However, it is possible that pulsatility plays less of a role in regulation of 
gonadotropic genes in Meishan females.  This may lead to the differential expression 
patterns observed compared to Index and Control gilts for the gonadotropin subunits and 
GnRHR.     
In addition to effects of GnRH pulse frequency, the concentration of GnRHRs on  
the gonadotrope cell membrane may affect gonadotropin subunit gene expression.  It is  
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possible that GnRH signaling cascades may differ at low compared to high GnRHR 
numbers.  The level of membrane bound GnRHR or differential G-protein activation of 
second messenger systems may explain the differential regulation of FSHβ- and LHβ-
subunit expression by GnRH (Stanislaus et al., 1998).   In both somatomammotrope-
derived GH3 (Kaiser et al., 1995) and gonadotrope-derived LβT2 (Bedecarrats and Kaiser, 
2003) cells, treatment with GnRH resulted in an increase in α- and LHβ-subunit gene 
expression at increasingly greater concentrations of GnRHR, whereas expression of the 
FSHβ-subunit gene was most favorable at lower concentrations.  Therefore, control of the 
FSHβ-subunit appears to be dependent on the concentration of GnRHR on the membrane 
of gonadotrope cells.  Once bound, GnRHR may couple with different G-proteins 
depending on receptor concentration.  This may occur due to differential activation of 
various α and βγ G-protein subunits (Kaiser et al., 1995).  Thus, while all three 
gonadotropin subunits are stimulated by GnRH at low levels of GnRHR, the α- and LHβ-
subunits are expressed at a higher level with increasing GnRHR concentrations through 
further activation of the same pathway and inhibition of the FSHβ-subunit, through a 
completely different pathway.   
While GnRHR numbers were not measured in the current study, it is possible that 
the amount of GnRHRs present on gonadotropes of ovariectomized Meishan gilts is more 
suitable for production of all gonadotropin subunits than receptor numbers in Index and 
Control gilts.  Consistent with this, levels of GnRHR mRNA were higher in Meishan than 
Index and Control gilts following treatment with SB-75.   It is also possible that without 
normal feedback from the gonads, gonadotropes of ovariectomized Meishans are not 
sensitive to treatment with a GnRH antagonist.  Finally, it is possible that mRNA poly(A) 
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tail lengthening in Meishan gilts occurs with not only the LHβ- and α-subunits, but also 
FSHβ-subunit and GnRHR, thus increasing half-life and exhibiting no difference in 
expression as was observed in the current study.  The length of LHβ- and α-subunit 
poly(A) tails increased following ovariectomy in the rat, as well as with GnRH pulses in 
rat pituitary cultures, which may allow post-transcriptional control of gonadotropin 
mRNA stability or translational efficiency (Weiss et al, 1992a).   
Others have investigated gene expression in anterior pituitaries of the Index and 
Control lines.  Bertani and associates (2004) reported greater expression of the α-subunit 
in pituitaries from the Control line compared to the Index line using differential display 
PCR.  In the same study, FSHβ-subunit gene expression was greater in pituitaries of 
females from the Index line than anterior pituitary tissue of the Control line.  It was 
suggested that the observed increase in FSHβ-subunit expression was due to direct 
selection for enhanced reproductive traits (Bertani et al., 2004).  In our study, however, 
pituitary expression levels of the α- and FSHβ-subunits for ovariectomized Control and 
Index females were similar for both genes.  In our experiment, the gilts were 
ovariectomized, removing ovarian feedback whereas intact animals were used in the 
study by Bertani and associates (2004).  A number of ovarian hormones, such as 
estradiol-17β and inhibin can influence expression of gonadotropin subunits and may 
have affected mRNA levels of the α- and FSHβ-subunits in the intact sows as compared 
to ovariectomized gilts.  Further, the discrepancy between studies may be due to the age 
of the animals as those used in the study by Bertani et al. (2004) were second parity sows 
and those used in the current study were gilts.  Bertani and associates also induced 
luteolysis between Day 12 and 14 of the estrous cycle and collected pituitaries 2 and 4 
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days later.  This may provide an inaccurate characterization of the gonadotropin subunit 
genes in an induced compared to normal follicular phase.     
In summary, treatment of ovariectomized gilts with the GnRH antagonist, SB-75, 
caused a reduction in serum levels of LH in all lines, but levels of FSH were reduced in 
Control animals only.  Expression of the GnRHR, α-, FSHβ- and LHβ-subunit genes was 
reduced in pituitaries of Index and Control line gilts, but not the Meishan line following 
SB-75 treatment.  This implies a differential mechanism in gene regulation and 
production of gonadotropins between Meishan and white crossbred lines of gilts.  Also, 
post-treatment levels of anterior pituitary GnRHR and LHβ-subunit mRNA were 
significantly higher in females of the Meishan line as compared to both Control and 
Index lines, suggesting that basal expression levels of these genes are increased in 
Meishan gilts.  Identification of such a trait, or traits, which could be easily screened and 
correlated with OR in young animals would be of great interest for selection purposes.  
This would allow even greater responses if the correlated trait could be measured in both 
male and female animals (Smith et al., 1983).  Further research needs to be conducted 
to elucidate the mechanisms controlling the observed differences in regulation of GnRHR 
and gonadotropin subunit gene expression between Meishan and white crossbred lines of 
swine.   
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CHAPTER V 
 
Microarray Analysis of GnRH Responsive Gene Expression in Anterior Pituitary 
Tissue of Swine Lines Divergent for Ovulation Rate 
 
Abstract 
A fundamental control point for reproductive function in mammals is the binding 
of GnRH to its receptor, an interaction that leads to the production and release of the 
gonadotropins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH).  
Additionally, the porcine GnRHR gene is a positional candidate for genes that influence 
reproductive efficiency because it is located in a similar chromosomal region to a 
quantitative trait locus (QTL) for ovulation rate (OR).  Analysis of GnRH responsive 
gene expression within anterior pituitary tissue of swine lines divergent for OR may 
provide insight into the mechanisms that control OR, and subsequently increased litter 
size.  Chinese Meishan (OR = 14.5), a white crossbred line selected for several 
generations based on an index of OR and embryonic survival (Index; OR = 17.8), and a 
control line (Control; OR = 13.2) were evaluated in this study.  Following three (Index 
and Control) or six (Meishan) successive estrous cycles, gilts were ovariectomized to 
remove endogenous steroid hormones.  After a 21 d recovery period, gilts from each line 
were treated with either a specific GnRH antagonist (SB-75) or 0.9% saline (vehicle) at 
60, 36 and 12 h prior to sacrifice.  The anterior pituitary was removed and total RNA 
extracted and pooled from 5 or 6 animals for each breed x treatment group (n = 6).  
Affymetrix GeneChip® Porcine Genome Arrays were run on each RNA pool in duplicate 
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and gene expression analyzed.  Treatment with the GnRH antagonist, SB-75, decreased 
or increased expression of 30, 17 and 33 genes in Control, Index and Meishan gilts, 
respectively, of which 14, 7 and 11 genes were expressed at greater than 2-fold over gilts 
treated with vehicle.  Twenty-three genes were down-regulated in Control gilts and 7 
genes had increased expression levels compared to vehicle treated females.  Expression 
of 12 genes was decreased in the anterior pituitary glands of Index line gilts, whereas 
only 5 genes were up-regulated following treatment with SB-75.  Gene expression in 
ovariectomized Meishan gilts was increased and decreased in 25 and 8 genes, 
respectively.  Of interest were two genes, a member of the peptidase M23/M37 family 
and an unknown gene, which were decreased in the anterior pituitary tissue of all swine 
lines.       
 
Introduction 
 Reproductive efficiency is of great importance to pork production as even a small 
increase in average litter size holds the potential to increase profitability.  Although litter 
size in the U.S. improved during the last 15 years, the national average of 8.9 pigs per 
litter (USDA, 2004) remains sub-optimal.  Litter size is influenced by many factors; 
however, a primary determinant of litter size is OR.  In addition, OR is a trait that differs 
significantly between strains of swine.   
 Gonadotropin-releasing hormone is a key molecule underlying regulation of 
reproductive function in mammals.  Upon binding to specific, high-affinity receptors on 
gonadotrope cells of the anterior pituitary gland, GnRH stimulates the synthesis and 
secretion of LH and FSH – two hormones which are essential for normal reproductive 
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function in both males and females (Clayton and Catt, 1981; Clarke et al., 1983; Mason et 
al., 1986).  In addition to changes in levels of GnRH secretion, changes in the number of 
pituitary receptors for GnRH have been implicated as an important mechanism 
underlying regulation of LH and FSH secretion.  Thus, regulation of gonadotropin 
secretion is dependent not only on GnRH availability, but also on the number of GnRH 
receptors and, consequently, the sensitivity of the pituitary gland to a given dose of 
GnRH (Wise et al., 1984).  Similarly, GnRH and several other hormones have been 
shown to regulate GnRHR numbers in the anterior pituitary gland (Sealfon and Millar, 
1995).  This increase in GnRHR numbers by GnRH is, in part, due to transcriptional 
regulation of the GnRHR gene, especially since changes in GnRHR numbers associated 
with GnRH treatments are correlated with changes in steady-state levels of mRNA 
(Kaiser et al., 1993; Turzillo et al., 1994; Bauer-Dantoin et al., 1995).  Thus, the 
interaction between GnRH and its cognate pituitary receptor serves as a central point for 
regulation of reproductive function. 
 From a physiological perspective, FSH and LH stimulate two principal 
components of ovulation rate, follicle recruitment and ovulation, respectively. Also, in 
contrast to the GnRHR gene from other species, the porcine GnRHR gene is located in 
the same chromosomal region as a QTL for ovulation rate (Rohrer et al., 1999).  
Therefore, the GnRHR gene represents both a physiological and positional candidate for 
genes determining ovulation rate in pigs.  Consistent with this, we have detected a 
quantitative difference in GnRHR mRNA levels between lines of swine divergent for 
ovulation rate (Chapter IV).  Additionally, differences in promoter activity of the GnRHR 
gene have been established between lines of swine divergent for OR (McDonald et al., 
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unpublished data).  Therefore, it is important to identify potential downstream effectors 
influenced by the interaction between GnRH and its receptor and their role in 
determination of OR in swine.      
Toward this end, we used three lines of pigs which differed in OR.  Chinese 
Meishan females are very prolific as they produce four to five more pigs per litter than 
their occidental counterparts, due, in part, to an increased OR (Christenson et al., 1993; 
White et al., 1993).  Consistent with this model, researchers at the University of Nebraska 
developed a line of swine (Index) based on a selection index of OR and embryonic 
survival.  This line of swine ovulates seven more eggs each cycle (Generation 10; 
Johnson et al., 1999) and produces 2.53 more live born piglets per litter than control 
animals (Control; Generation 19; Petry and Johnson, 2004).  Although OR has been 
extensively studied (Bennet and Leymaster, 1989), the genetic mechanisms that 
determine OR in the pig remain unknown.  The recent introduction of the Affymetrix 
GeneChip® Porcine Genome Array creates a platform to identify multiple genes that may 
be regulated by GnRH in the anterior pituitary of these swine models for determination of 
OR.  This is likely given that it has been established by microarray analysis in 
gonadotrope-derived LβT2 cells that over 200 genes are regulated by GnRH (Kakar et al., 
2003).  In the current study, we examined gene expression in the porcine anterior 
pituitary gland following treatment with or without a GnRH antagonist of ovariectomized 
gilts from lines of swine divergent for OR.    
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Materials and Methods 
Animals 
 All animal procedures used in this study were approved by the UNL Institutional 
Animal Care and Use Committee.  White crossbred Index and Control line gilts 
(Generation 23) were transported to the UNL Animal Science Building from the 
University of Nebraska Agricultural Research and Development Center (ARDC) Swine 
Unit.  Gilts of the Meishan breed were transported to the Animal Science Building from 
the United States Department of Agriculture, Roman L. Hruska U.S. Meat Animal 
Research Center in Clay Center, Nebraska.  Gilts were housed in pens with a minimum of 
8 square feet of floor space, 4 pounds of feed per day and water available ad libitum.  
Gilts of the Index and Control lines were detected for estrus beginning at 155 days of age 
whereas estrous detection began at 95 days of age for Meishan females.   
 
Treatments 
Upon completion of the third (Index and Control) or sixth (Meishan) estrus, ten 
gilts from the Index and Control lines, and 12 Meishan gilts were ovariectomized during 
the luteal phase (Day 5 through 15 of the estrous cycle).  On the basis of a preliminary 
study in our laboratory, and previous reports (Christenson et al., 1993; Hunter et al., 
1993), Meishan females were allowed an additional three estrous cycles to increase OR to 
a level above control gilts as Meishan gilts do not exhibit an increased OR following 
three estrous cycles when compared to gilts from occidental breeds.  Twenty-one days 
after ovariectomy, gilts from each line were randomly assigned to treatment groups and 
received an injection of either the specific GnRH antagonist, SB-75, (10 μg of 
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biologically active compound per kg of bodyweight; UNL Protein Core Facility), or 
vehicle (0.9% saline) at 60, 36 and 12 hours prior to sacrifice.   
  
Tissue Collection and RNA Extraction 
Gilts from the Index, Control, and Meishan lines were transported to the UNL 
abattoir the morning of sacrifice.  Animals were rendered unconscious by electrical 
stunning followed by exsanguination.  The pituitary gland was excised and transferred to 
a sterile Petri dish using RNase-free utensils.  The anterior and posterior pituitaries were 
separated and the anterior pituitary was divided into quarters (approximately 65 mg of 
tissue each) and placed in RNAlater (Ambion, Inc., Austin, TX) on ice for later RNA 
extraction.  Tissue was removed from the RNAlater solution and RNA extracted using 
the RNeasy Midi Kit as per manufacturer’s instructions (Qiagen, Inc., Valencia, CA).  
Following extraction, total RNA was pooled within breed x treatment groups (n = 5 to 6 
gilts per group) and precipitated by adding 0.3 M sodium acetate followed by 1 volume 
of isopropanol.  The solution was mixed and incubated at -20°C for one hour, at which 
time it was centrifuged at 12,000 x g for 30 minutes at 4°C.  Following centrifugation, the 
supernatant was removed and the resulting pellet was washed with 70% ethanol.  The 
ethanol was removed and the pellet was allowed to dry.  The RNA pellet was then 
resuspended in 100 μl RNase-free water.  To this, 350 μl of Buffer RLT (Qiagen, Inc.) 
was added followed by 250 μl of 100% ethanol.  After mixing, the solution was applied 
to an RNeasy Mini column placed in a 2-ml collection tube and centrifuged at 8,000 x g 
for 15 seconds.  The RNeasy Mini column was then transferred to a new 2-ml collection 
tube.  To the column, 500 μl of Buffer RPE was added and it was centrifuged as 
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described above.  The flow-through was discarded and an additional 500 μl of Buffer 
RPE was added to the column.  This was followed by centrifugation at 8,000 x g for 2 
minutes.  The RNeasy Mini column was then placed in a fresh 1.5-ml tube and 35 μl of 
RNase-free water was added to the column followed by centrifugation at 8,000 x g for 1 
minute.   
Pooled RNA was quantified using RiboGreen (Molecular Probes), diluted to a 
concentration of 2 μg/μl and delivered to the Genomics Core Research Facility (UNL).  
Pooled samples were analyzed for quality and integrity using an Agilent 2100 
bioanalyzer (Agilent Technologies, Inc.).  The Affymetrix GeneChip® System uses arrays 
fabricated by direct synthesis of oligonucleotide probes on glass slides using 
photolithographic technology.  Hybridization to the chip is DNA:RNA.  Antisense copy 
RNA (cRNA), made from double stranded cDNA that was derived from the mRNA 
samples, was transcribed in vitro using T7 RNA polymerase in the presence of 
biotinylated CTP and UTP.  The hybridized probe array was stained with streptavidin 
phycoerythrin conjugate and scanned by the GeneChip® Scanner 3000 (Affymetrix, Inc.). 
The amount of light emitted at 570 nm is proportional to the bound target at each location 
on the probe array.  Pooled samples from each breed x treatment group (n = 6) were 
hybridized on separate chips and then compared after analysis.  Analysis of image data 
was achieved using GeneChip® Operating Software (Version 1.2; Affymetrix, Inc.).  
Each pooled sample was run in duplicate.  Normalized data from the GeneChip® 
Operating Software package was analyzed using GeneSifter (VizX Labs LLC, Seattle, 
WA; http://www.genesifter.net).  Differential expression of genes was determined by 
averaging duplicate arrays and running a pair-wise analysis. Statistical significance was 
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determined by Student’s t test and genes with differences (P < 0.05) were included in the 
analysis. 
 
Results and Discussion 
 The interaction between GnRH and its receptor is of great interest because it 
represents a central point for regulation of reproductive function.  The binding of GnRH 
to its receptor enables the synthesis and secretion of FSH and LH – key components to 
determination of OR in pigs.  Further, the binding of GnRH to GnRHR leads to up-
regulation of genes encoding the subunits that comprise the gonadotropins as well as the 
GnRHR gene itself.  In addition, the GnRHR represents both a physiological and 
positional candidate for genes that influence OR.  Therefore, it is important to gain a 
better understanding of GnRH responsive gene expression among lines of swine to 
examine if differential mechanisms exist for determination of OR. 
 To determine the expression profile of GnRH responsive anterior pituitary genes 
we used the Affymetrix GeneChip® Porcine Genome array which contains 23,937 probes 
sets that examine 23,256 transcripts from 20,201 genes.  Antisense copy RNA prepared 
from the anterior pituitary gland of vehicle treated gilts was used for comparative 
analysis.  The signal intensity of the arrays for various housekeeping genes and ribosomal 
RNA were used to normalize expression of the genes.  Relative expression levels were 
visualized by plotting the SB-75 vs. vehicle treated intensities (Fig. 5.1). 
 The expression analysis revealed 68 genes that were up- or down-regulated in the 
anterior pituitary gland of ovariectomized gilts from all three lines following treatment 
with the GnRH antagonist, SB-75 (Table 5.1).  Of the 68 genes, 23 displayed differences  
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Figure 5.1.  Pituitary gene expression following treatment with the GnRH antagonist, 
SB-75, in lines of swine divergent for ovulation rate.  Data for two arrays from each 
breed x treatment group are shown as a scatter plot comparing expression of SB-75 vs. 
vehicle treated (A) Control, (B) Index and (C) Meishan gilts.   
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in pituitary expression levels following SB-75 treatment of 2-fold or more, and five were 
expressed at greater than 4-fold compared to vehicle.  Within pituitaries from Control 
gilts there were 23 down-regulated genes and 7 up-regulated genes compared to those of 
vehicle treated females.  Expression of 12 genes was decreased in the Index line, whereas 
only five genes were increased following treatment with SB-75.  Gene expression in 
ovariectomized Meishan gilts was down- and up-regulated for 8 and 25 genes, 
respectively, after SB-75 treatment.  Pituitary expression of two genes were decreased in 
all lines, five genes were either decreased or increased in Control and Meishan, two genes 
were decreased in Control and Index, and one gene was decreased in Index and Meishan 
following exposure to the GnRH antagonist. 
 Analysis using microarray technology has revealed multiple genes that are 
responsive to GnRH in the anterior pituitary glands of swine lines divergent for OR.  
However, the identity of many of the genes remains unknown.  For example, one of the 
two genes that are down-regulated by SB-75 treatment in all three lines of swine has an 
unknown identity.  While expression of the unknown gene is down-regulated between 
2.0- and 2.5-fold, it is the other gene, a homologue to the peptidase M23/M37 family, that 
is the most interesting as expression levels decreased 7.0-, 4.3- and 3.2-fold in pituitaries 
of Control, Index and Meishan gilts, respectively, after treatment with SB-75 (Table 5.2). 
 Also of interest are genes that are up- or down-regulated by the GnRH antagonist 
in two of the three lines of pigs.  Expression of genes encoding neuronal pentraxin II 
(NP2), very low density lipoprotein receptor, and phospholipase C, gamma 2 (PLCγ2) are 
decreased whereas DNA-damage-inducible transcript 4-like (DDIT4L) and an unknown 
gene are up-regulated in pituitaries of SB-75 vs. vehicle treated Control and Meishan gilts.  
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Control and Index females share a down-regulation of Complement 4 and the 
hypothetical protein SAG0245 after SB-75 treatment, whereas Index and Meishan gilts 
have decreased expression levels of the gene encoding V-ATPase C2 subunit in common 
(Table 5.2). 
 Neuronal pentraxin II is a member of the pentraxin family of proteins which are 
capable of forming pentameric complexes (Kao et al., 2003).  Members of the pentraxin 
family, including NP2, are involved in neuronal function (Garlanda et al., 2005).  It has 
been suggested that NP2 may function to remove degraded synaptic material during 
formation and remodeling of synapses (Dodds et al., 1997).  Additionally, NP2 is 
implicated in synaptic plasticity in the vestibular system, participating in adjustments in 
synaptic efficacy or connectivity (Reti et al., 2002).  Since GnRH is released from 
hypothalamic neurons and travels to its receptors on gonadotropes in the anterior pituitary 
gland, it is unclear what role NP2 may have in the anterior pituitary gland in the lines of 
swine studied. 
 Phospholipase C-gamma 2 generates inositol triphosphate and diacylglycerol 
following activation of tyrosine kinase receptors, but at a much slower rate than G 
protein-coupled receptors (Berridge, 1993).  Additionally, it has been suggested that 
PLCγ2 is required for agonist-induced activation of calcium influx into the cell (Patterson 
et al., 2002).  While PLCγ2 is probably affected indirectly from GnRH antagonist 
treatment, it may offer an alternative means of calcium intake following GnRH 
stimulation. 
 Another gene of particular interest is early growth response protein 1 (Egr-1) 
which was down-regulated in Control females following SB-75 treatment.  Early growth  
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TABLE 5.2.  FOLD-CHANGES IN PITUITARY GENE EXPRESSION IN LINES OF 
SWINE DIVERGENT FOR OVULATION RATE DETERMINED BY AFFYMETRIX 
GENECHIP® PORCINE GENOME ARRAY 
homologue to 
very low density 
lipoprotein 
receptor
TC204812CF365775
homologue to 
phospholipase
C, gamma 2
TC227308CN166587
similar to DNA-
damage-
inducible 
transcript 4-like
----------BI182553
?----------CN031558
Complement 4TC199890CF366280
Similar to 
hypothetical 
protein SAG0245
TC209620BQ602610
similar to 
neuronal 
pentraxin II
TC214846BX666127
?TC225079 BQ601267 
homologue to 
V-ATPase C2 
subunit
TC219862BI404208
homologue to 
(Q8G137) 
Peptidase 
M23/M37 family
TC228784 AW415941 
Fold ChangeDescriptionTIGR Accession 
Number
GenBank 
Accession 
Number
Control -7.03
Meishan      -3.20
Index          -4.29
Control -2.55
Index          -2.49
Meishan      -2.03
Control        -6.01
Meishan    -3.63
Control -1.51
Meishan -1.64
Control        -2.67
Meishan      -2.10
Control        +1.94
Meishan      +2.13
Control        +2.18
Meishan      +2.34
Control        -3.44
Index           -2.09
Control        -1.70
Index           -2.01
Index          -3.08
Meishan      -2.73
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response protein 1 has been implicated in the transcriptional regulation of the rat α- and 
LHβ-subunit genes (Gajewska and Kochman, 2001; Yoshino et al., 2002).  The LHβ-
subunit contains an Egr-1 binding site that is part of a tripartite GnRH responsive element 
also comprised of a steroidogenic factor 1 (SF-1) and specificity protein 1 (Sp-1) site 
(Gajewska and Kochman, 2001).  In addition, it was determined that the rat LHβ-subunit 
promoter contains two overlapping EGR-1 consensus sequences between -171 and -137 
bp of proximal promoter to which Egr-1 binds independently (Yoshino et al., 2002).  
Further, it was demonstrated that GnRH rapidly stimulates expression of Egr-1 through 
PKC/ERK activation of several serum response/Ets elements and a cAMP response 
element (Duan et al., 2002).  
 In this study, we were interested in expression patterns of four genes in particular, 
the GnRHR, α-subunit, FSHβ- and LHβ-subunits, because of their possible role in 
determination of OR among swine lines (Table 5.3).  Expression levels of the GnRHR 
gene in all lines were numerically decreased, but not significantly, with the greatest 
decline in Index (1.42-fold) and Control (1.33-fold) gilts following SB-75 treatment.  No 
change in gene expression for the α-subunit and LHβ-subunit as determined by 
microarray analysis was observed among Control, Index or Meishan females treated with 
the GnRH antagonist compared to vehicle.  This was also true for expression patterns of 
the FSHβ-subunit gene in Control and Meishan gilts, whereas Index females (1.14-fold) 
had a non-significant numerical increase.  This is in contrast to real-time PCR data in 
which levels of the GnRHR, α-subunit, FSHβ- and LHβ-subunit mRNA were decreased 
by SB-75 treatment in Control and Index, but not Meishan females (Chapter IV).  The 
discrepancy between microarray and real-time PCR measurement of gene expression has 
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TABLE 5.3.  FOLD-CHANGES IN PITUITARY GNRHR, Α-SUBUNIT, FSHΒ- AND 
LHΒ-SUBUNIT GENE EXPRESSION IN LINES OF SWINE DIVERGENT FOR 
OVULATION RATE DETERMINED BY AFFYMETRIX GENECHIP® PORCINE 
GENOME ARRAY 
 
 Fold-decrease compared to Vehicle 
Gene Name Control Index Meishan 
GnRHR 1.33 1.42 1.17 
α-subunit 1.02 +1.01 +1.00 
FSHβ-subunit 1.06 1.14 +1.04 
LHβ-subunit 1.02 +1.08 +1.07 
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been observed in other studies (Wurmbach et al., 2001). 
 Expression analysis of anterior pituitary glands from ovariectomized gilts treated 
with the GnRH antagonist, SB-75, or vehicle provides insight into the regulation of 
several GnRH responsive genes.   Results of the array identified several known and 
unknown GnRH responsive genes that may be important in gonadotropin production, 
such as Egr-1.  Further research will continue to elucidate GnRH regulation of genes and 
signaling pathways in the anterior pituitary gland of swine and their role in determination 
of OR.   
TABLE 5.1.  PITUITARY EXPRESSION ANALYSIS OF LINES OF SWINE DIVERGENT FOR OVULATION RATE USING 
THE AFFYMETRIX GENECHIP® PORCINE GENOME ARRAY 
 
                Accession No.                                  Affymetrix Probe                 Clone ID                                           Description                          Fold-change 
    GenBank                       TIGR                                   vs. Vehicle 
 
Control Down-regulated 
 
AW415941 TC228784 Ssc.23329.1.S1_at  ---------------------------- homologue to (Q8G137) Peptidase M23/M37 family -7.03 
BX666127 TC214846 Ssc.22627.1.S1_at scag0007c.d.07 similar to Homo sapiens neuronal pentraxin II (BC035339) -6.01 
CN166439 TC220582 Ssc.3012.1.S1_at ----------------------------- similar to  UP|UPP1_MOUSE (P52624) Uridine phosphorylase 1  (UrdPase 1) (UPase 1) ,  partial (92%) -4.57 
CB285513 TC205551 Ssc.16460.1.S1_at PPSUBLIB_05B01 
homologue to  UP|EGR1_HUMAN (P18146) Early growth response protein 1 (EGR-1)  
(Krox-24 protein) (ZIF268) (Nerve growth factor-induced protein A) (NGFI-A)  
(Transcription factor ETR103) (Zinc finger protein 225) (AT225),  partial (20%) 
-4.15 
 
CF366280 TC199890 Ssc.17026.1.S1_at ----------------------------- UP|Q69DL1 (Q69DL1) Complement C4 (Fragment),  complete -3.44 
BQ603077 TC205573 Ssc.19629.2.S1_s_at MI-P-NA-afp-b-10-1-UM (Q6IP63) MGC78926 protein -3.33 
CO947935 TC217828 Ssc.30021.1.A1_at ----------------------------- -------------- -2.68 
CF365775 TC204812 Ssc.8564.1.A1_at ----------------------------- homologue to  UP|Q91YY0 (Q91YY0) Vldlr protein,  partial (28%) -2.67 
BQ601267 TC225079 Ssc.13431.1.A1_at MI-P-H3-afa-b-07-1-UM -------------- -2.55 
NM_214038  ------------ Ssc.141.1.S1_at ----------------------------- Sus scrofa prohormone convertase (PC13) -2.14 
AJ301332 TC221739 Ssc.10942.1.S1_at 09B02dT3 homologue to  UP|Q5XIV3 (Q5XIV3) Enolase 3, beta,  complete -2.10 
CK460825 TC221784 Ssc.17286.1.A1_at ----------------------------- similar to Human B-cell translocation gene 2 (HSU72649)  -2.06 
BX921013 TC235477 Ssc.25700.1.S1_at scan0004d.d.22 similar to  UP|Q8N5K8 (Q8N5K8) B-cell scaffold protein with ankyrin repeats 1,  partial (8%) -1.89 
BI184308 ------------ Ssc.11744.1.A1_at UNL-P-FN-ck-g-09-0-UNL similar to Bos taurus multiple coiled-coil GABABR1-binding protein (XM_589638) -1.85 
NM_214287 ------------ Ssc.16342.1.A1_at ----------------------------- Sus scrofa nexin-1 (PN-1) -1.80 
BX917032 ------------ Ssc.25458.1.S1_at scan0034d.b.15 similar to Homo sapiens testican-1 mRNA (AF231124) -1.72 
BQ602610 TC209620 Ssc.13529.1.A1_at MI-P-NA-aeo-b-10-1-UM similar to (Q8E1V6) Hypothetical protein SAG0245 -1.70 
BQ600663 TC204479 Ssc.5696.1.S1_at MI-P-E7-agz-h-04-1-UM homologue to  UP|PLE2_HUMAN (Q9NYT0) Pleckstrin 2,  complete -1.65 
 
(Table 5.1 continued) 
 
                Accession No.                                  Affymetrix Probe                 Clone ID                                           Description                          Fold-change 
    GenBank                       TIGR                                   vs. Vehicle 
 
Control Down-regulated 
 
BQ600843 TC211104 Ssc.1477.1.A1_at MI-P-E7-ahs-f-10-1-UM similar to (Q95UF3) Serine-threonine protein kinase -1.65 
CO954537 ------------ Ssc.29372.1.A1_at ----------------------------- 
similar to Homo sapiens phosphatidylinositol-specific phospholipase C, X domain containing 3  
(PLCXD3) (NM_001005473) 
-1.54 
CF180854 TC221412 Ssc.10931.1.S1_at ----------------------------- UP|Q7M2W6 (Q7M2W6) Alpha-b crystallin,  complete -1.51 
CK467066 TC220558 Ssc.17965.1.S1_at ----------------------------- similar to  UP|Q6DE63 (Q6DE63) MGC80058 protein,  partial (91%) -1.51 
CN166587 TC227308 Ssc.24329.1.A1_at ----------------------------- homologue to  UP|Q8CIH5 (Q8CIH5) Phospholipase C, gamma 2,  partial (10%) -1.51 
 
Control Up-regulated 
 
BX676059 TC201683 Ssc.15893.1.S1_at scag0009c.h.03 weakly similar to  UP|GSM1_HUMAN (P57764) Gasdermin domain containing protein 1,  partial (92%)  2.97 
CN031558 ------------ Ssc.28097.1.A1_at ----------------------------- --------------  2.18 
BI182553 ------------ Ssc.11437.1.A1_at UNL-P-FN-an-b-10-0-UNL similar to Homo sapiens DNA-damage-inducible transcript 4-like (DDIT4L) (NM_145244)  1.94 
CK461132 TC234893 Ssc.5333.1.S1_at ----------------------------- homologue to  UP|Q80TI6 (Q80TI6) MKIAA1170 protein (Fragment),  partial (13%)  1.93 
BI342348 TC226733 Ssc.6112.1.S1_at ----------------------------- --------------  1.87 
BI183043 TC237246 Ssc.11494.1.A1_at UNL-P-FN-bt-d-11-0-UNL similar to  UP|O72510 (O72510) Polyprotein (Fragment),  partial (10%)  1.56 
CF180368 TC225432 Ssc.18601.1.A1_at ----------------------------- --------------  1.50 
 
Index Down-regulated 
 
AW415941 TC228784 Ssc.23329.1.S1_at ----------------------------- homologue to (Q8G137) Peptidase M23/M37 family -4.29 
BI404208 TC219862 Ssc.31160.1.A1_s_at MI-P-CP1-nww-f-11-0-UI homologue to  UP|Q8NEY4 (Q8NEY4) V-ATPase C2 subunit,  partial (64%) -3.08 
CN158797 TC206965 Ssc.6219.1.A1_at ----------------------------- (P24903) Cytochrome P450 2F1 (CYPIIF1) (EC 1.14.14.1 EC 1.14.14.1 EC 1.14.14.1)  -2.52 
 (Table 5.1 continued) 
 
                Accession No.                                  Affymetrix Probe                 Clone ID                                           Description                          Fold-change 
    GenBank                       TIGR                                   vs. Vehicle 
 
Index Down-regulated 
 
BQ601267 TC225079 Ssc.13431.1.A1_at MI-P-H3-afa-b-07-1-UM -------------- -2.49 
CN153818 TC223395 Ssc.27166.1.S1_at ----------------------------- UP|Q6DLU9 (Q6DLU9) 6A3-5 protein,  complete -2.19 
CF366280 TC199890 Ssc.17026.1.S1_at ----------------------------- UP|Q69DL1 (Q69DL1) Complement C4 (Fragment),  complete -2.09 
BQ602610 TC209620 Ssc.13529.1.A1_at MI-P-NA-aeo-b-10-1-UM similar to (Q8E1V6) Hypothetical protein SAG0245 -2.01 
BI360888 TC199713 Ssc.4957.1.S1_at ----------------------------- homologue to (Q6PEZ8) Hypothetical protein FLJ23447 -1.71 
CF180652 TC202026 Ssc.5118.1.S1_at ----------------------------- 
homologue to  UP|A8B1_HUMAN (O43520) Potential phospholipid-transporting ATPase IC   
(Familial intrahepatic cholestasis type 1) (ATPase class I type 8B member 1) ,  partial (64%) 
-1.70 
BI400383 ------------ Ssc.10264.1.A1_at MI-P-AY1-nqw-a-08-0-UI similar to Human protein tyrosine phosphatase mRNA (M64572) -1.65 
BQ601792 TC209582 Ssc.14310.1.A1_at MI-P-HO-afx-c-02-1-UM homologue to  UP|Q5SWM5 (Q5SWM5) Novel zinc finger protein,  partial (6%) -1.57 
CK456522 TC211611 Ssc.24067.1.A1_at ----------------------------- similar to (Q60KN8) Hypothetical protein CBG23978 -1.55 
 
Index Up-regulated 
 
BQ604090 ------------ Ssc.30883.1.A1_at MI-P-CP1-nza-o-21-0-UI similar to Homo sapiens GREB1 protein (GREB1), transcript variant a (NM_014668)  1.62 
NM_214337 ------------ Ssc.13002.1.S1_at ----------------------------- Sus scrofa 17-kDa PKC-potentiated inhibitory protein of PP1 (PPP1R14A)  1.55 
CO956777 TC202434 Ssc.6478.1.A1_at ----------------------------- similar to  UP|CCD3_MOUSE (Q9D6Y1) Coiled-coil domain containing protein 3 precursor,  partial (38%)  1.52 
BX914448 TC206366 Ssc.26203.1.S1_at scan0001f.d.23 similar to  UP|KF12_HUMAN (Q96FN5) Kinesin-like protein KIF12 (Fragment),  partial (96%)  1.50 
CF792374 TC222623 Ssc.22063.1.S1_at ----------------------------- homologue to  UP|EXC7_RAT (O54922) Exocyst complex component 7 (Exocyst complex component Exo70) (rExo70),  partial (63%)  1.50 
 
Meishan Down-regulated 
 
BX666127 TC214846 Ssc.22627.1.S1_at scag0007c.d.07 similar to Homo sapiens neuronal pentraxin II (BC035339) -3.63 
 (Table 5.1 continued) 
 
                Accession No.                                  Affymetrix Probe                 Clone ID                                           Description                          Fold-change 
    GenBank                       TIGR                                  vs. Vehicle 
 
Meishan Down-regulated 
 
AW415941 TC228784 Ssc.23329.1.S1_at ----------------------------- homologue to (Q8G137) Peptidase M23/M37 family -3.20 
BI404208 TC219862 Ssc.31160.1.A1_s_at MI-P-CP1-nww-f-11-0-UI homologue to  UP|Q8NEY4 (Q8NEY4) V-ATPase C2 subunit,  partial (64%) -2.73 
BQ603633 TC224265 Ssc.4552.1.S1_at MI-P-CP0-nvg-h-03-0-UI homologue to  GB|BAA03946.1|391736|HUMVLDLRB very low density lipoprotein receptor  {Homo sapiens;} ,  partial (42%) -2.10 
 
BQ601267 TC225079 Ssc.13431.1.A1_at MI-P-H3-afa-b-07-1-UM -------------- -2.03 
CF365775 TC204812 Ssc.8564.1.A1_at ----------------------------- homologue to  UP|Q91YY0 (Q91YY0) Vldlr protein,  partial (28%) -2.02 
CK462890 TC219862 Ssc.14999.1.A1_at ----------------------------- homologue to  UP|Q8NEY4 (Q8NEY4) V-ATPase C2 subunit,  partial (64%) -1.67 
CN166587 TC227308 Ssc.24329.1.A1_at ----------------------------- homologue to  UP|Q8CIH5 (Q8CIH5) Phospholipase C, gamma 2,  partial (10%) -1.64 
 
Meishan Up-regulated 
 
CN031558 ------------ Ssc.28097.1.A1_at ----------------------------- --------------  2.34 
CO956126 TC204810 Ssc.9688.1.S1_at ----------------------------- (O43005) SPBC2G2.06c protein (Apl1 protein)  2.27 
AW480026 TC233646 Ssc.30625.1.S1_at ----------------------------- similar to (Q60D66) Hypothetical protein OSJNBa0073C10.14  2.13 
BI182553 ------------ Ssc.11437.1.A1_at UNL-P-FN-an-b-10-0-UNL similar to Homo sapiens DNA-damage-inducible transcript 4-like (DDIT4L) (NM_145244)  2.13 
BI119477 TC203393 Ssc.7093.3.S1_at ----------------------------- similar to UP|Q9NF31 (Q9NF31) EG:BACN25G24.3 protein (Fbgn0004860;ph-d protein)  2.05 
CO987486 TC226214 Ssc.31164.1.S1_at ----------------------------- similar to (Q671A1) Ellis van Creveld protein-like  1.87 
CK457106 TC227683 Ssc.24173.1.S1_at ----------------------------- similar to Homo sapiens transmembrane protein 46 (TMEM46) (NM_001007538)  1.81 
BQ597811 ------------ Ssc.10731.1.A1_at MI-P-A2-afg-a-12-1-UM similar to Homo sapiens pregnancy-associated plasma protein A, pappalysin 1 (BC078657)  1.80 
 
 
 
 
(Table 5.1 continued) 
 
                Accession No.                                  Affymetrix Probe                 Clone ID                                           Description                          Fold-change 
    GenBank                       TIGR                                   vs. Vehicle 
 
Meishan Up-regulated 
 
AJ656944 TC205995 Ssc.14352.1.S1_at C0005194_A20 similar to (Q7YX45) Hypothetical protein F07B10.4  1.78 
BQ602964 ------------ Ssc.13635.1.A1_at MI-P-NA-aes-e-12-1-UM --------------  1.78 
CF789721 TC237052 Ssc.22266.1.A1_at ----------------------------- homologue to (Q661N6) Basic membrane protein A1 precursor (Immunodominant antigen P39)  1.71 
BQ603378 TC233830 Ssc.2834.1.A1_at MI-P-NA-afs-g-11-1-UM UP|GIDB_MYCGE (P47620) Methyltransferase gidB  (Glucose inhibited division protein B) ,  partial (5%)  1.69 
CF368424 TC205594 Ssc.1609.1.A1_at ----------------------------- similar to (Q74LP0) Hypothetical protein  1.61 
CK461456 TC222351 Ssc.19651.1.S1_at ----------------------------- similar to  UP|Q655C0 (Q655C0) Seed specific protein, 5'-partial-like protein,  partial (6%)  1.60 
CN069958 TC222178 Ssc.6218.1.S1_at ----------------------------- homologue to  UP|Q62CX7 (Q62CX7) Oxidoreductase, short-chain dehydrogenase/reductase family,  partial (5%)  1.60 
 
NM_001001865 ------------ Ssc.20177.1.S1_at ----------------------------- Sus scrofa transcription factor PU.1  1.59 
BF198220 TC221910 Ssc.4029.1.S1_a_at ----------------------------- homologue to  UP|SHB2_HUMAN (Q9NR46) SH3 domain GRB2-like protein B2 (Endophilin B2) (PP578),  partial (91%)  1.58 
 
CF792574 TC218158 Ssc.22390.1.A1_at ----------------------------- (Q6ZU13) Hypothetical protein FLJ44064  1.58 
CN163273 TC201594 Ssc.21436.1.S1_at ----------------------------- homologue to  UP|Q9P1S7 (Q9P1S7) HDCMA18P,  complete  1.56 
BF708730 TC212964 Ssc.8919.1.S1_at MI-P-AY0-nai-b-05-0-UI --------------  1.55 
CN166215 ------------ Ssc.27062.1.A1_at ----------------------------- --------------  1.55 
CO987060 TC223977 Ssc.25067.1.S1_at ----------------------------- similar to  UP|DAPB_NITEU (Q82WP9) Dihydrodipicolinate reductase  (DHPR) ,  partial (5%)  1.54 
BI400498 TC216136 Ssc.10007.1.A1_at MI-P-AY1-nrw-g-01-0-UI similar to (Q8HG39) NADH dehydrogenase subunit 5  1.52 
CA778753 TC219247 Ssc.23486.1.S1_at pSPORT1 
homologue to  UP|Q9DCM0 (Q9DCM0) Mus musculus adult male kidney cDNA,  
RIKEN full-length enriched library, clone:0610025L15 product:PROTEIN EXPRESSED IN THYROID  
homolog (ETHE1 protein) (HSCO protein),  complete 
 1.51 
 
CO950299 TC225152 Ssc.66.1.S3_at ----------------------------- (Q7RMM2) Hypothetical protein  1.51 
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